Track market-moving stories before they get noisy

Posted by Defense World Staff on Jul 21st, 2026

AlTi Global Inc. acquired a new stake in Energy Transfer LP (NYSE:ET – Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 65,458 shares of the pipeline company’s stock, valued at approximately $1,263,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in ET. Basepoint Wealth LLC acquired a new position in Energy Transfer during the 4th quarter valued at about $25,000. Gables Capital Management Inc. grew its position in shares of Energy Transfer by 60.0% during the 4th quarter. Gables Capital Management Inc. now owns 1,600 shares of the pipeline company’s stock worth $26,000 after buying an additional 600 shares during the period. Sarver Vrooman Wealth Advisors acquired a new stake in shares of Energy Transfer during the 4th quarter worth approximately $32,000. Navalign LLC bought a new stake in shares of Energy Transfer during the fourth quarter worth approximately $37,000. Finally, Vermillion Wealth Management Inc. raised its stake in shares of Energy Transfer by 69.5% during the fourth quarter. Vermillion Wealth Management Inc. now owns 2,351 shares of the pipeline company’s stock worth $39,000 after buying an additional 964 shares during the last quarter. 38.22% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes A number of equities analysts have issued reports on ET shares. Scotiabank reaffirmed an “outperform” rating on shares of Energy Transfer in a research note on Tuesday, May 12th. TD Cowen reiterated a “buy” rating and set a $24.00 target price (up from $23.00) on shares of Energy Transfer in a research report on Thursday. Truist Financial began coverage on Energy Transfer in a research note on Tuesday, March 24th. They issued a “buy” rating and a $23.00 price target on the stock. Weiss Ratings restated a “buy (b)” rating on shares of Energy Transfer in a research report on Friday, June 5th. Finally, Barclays reaffirmed an “overweight” rating and set a $23.00 price objective (up from $22.00) on shares of Energy Transfer in a research note on Thursday, May 14th. Three analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Energy Transfer presently has an average rating of “Buy” and an average price target of $23.55.

View Our Latest Analysis on Energy Transfer

Energy Transfer Stock Down 0.2% Shares of NYSE:ET opened at $20.28 on Tuesday. The company has a 50 day moving average price of $19.53 and a two-hundred day moving average price of $18.88. The company has a debt-to-equity ratio of 1.50, a quick ratio of 0.93 and a current ratio of 1.17. The company has a market capitalization of $69.77 billion, a PE ratio of 16.90, a PEG ratio of 1.18 and a beta of 0.55. Energy Transfer LP has a 52 week low of $16.18 and a 52 week high of $20.70.

Energy Transfer (NYSE:ET – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The pipeline company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Energy Transfer had a return on equity of 9.77% and a net margin of 4.66%.The firm had revenue of $27.77 billion for the quarter, compared to the consensus estimate of $25.78 billion. During the same period in the prior year, the business earned $0.36 earnings per share. The company’s revenue for the quarter was up 32.1% compared to the same quarter last year. Analysts forecast that Energy Transfer LP will post 1.43 earnings per share for the current year.

Energy Transfer Increases Dividend The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Friday, May 8th were issued a dividend of $0.3375 per share. This is a boost from Energy Transfer’s previous quarterly dividend of $0.34. This represents a $1.35 annualized dividend and a yield of 6.7%. The ex-dividend date was Friday, May 8th. Energy Transfer’s dividend payout ratio is presently 112.50%.

Energy Transfer Company Profile (Free Report)

Energy Transfer (NYSE: ET) is a Dallas-based midstream energy company that develops and operates infrastructure for the transportation, storage and processing of hydrocarbons. The company’s operations focus on moving and storing natural gas, natural gas liquids (NGLs), crude oil and refined products through an integrated network of pipelines, terminals, storage facilities and processing plants. Energy Transfer provides core midstream services such as gathering, compression, fractionation, processing, and bulk transportation to support production and downstream supply chains.

Its asset base spans an extensive network across the United States, connecting producing regions, processing centers, petrochemical hubs and coastal and inland markets.

Further Reading Five stocks we like better than Energy Transfer The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Energy Transfer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Energy Transfer and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlTi Global Inc. Has $1.14 Million Holdings in Paramount Skydance Corporation $PSKY

NEXT HEADLINE »AlTi Global Inc. Sells 1,847 Shares of Vanguard Small-Cap ETF $VB

Macro Bank (BMA - Free Report) : This leading bank in Argentina has a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.

Macro Bank has a PEG ratio of 0.58 compared with 0.86 for the industry. The company possesses a Growth Score of A.

Five Below, Inc. (FIVE - Free Report) : This specialty retail company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.

Five Below has a PEG ratio of 1.07 compared with 2.14 for the industry. The company possesses a Growth Score of A.

Dycom Industries, Inc. (DY - Free Report) : This infrastructure services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.1% over the last 60 days.

Dycom Industries has a PEG ratio of 0.68 compared with 1.24 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC decreased its holdings in Rollins, Inc. (NYSE:ROL – Free Report) by 17.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 438,205 shares of the business services provider’s stock after selling 91,994 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.09% of Rollins worth $23,440,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Norges Bank bought a new position in shares of Rollins during the fourth quarter worth approximately $244,669,000. Pictet Asset Management Holding SA grew its position in Rollins by 188.2% during the first quarter. Pictet Asset Management Holding SA now owns 2,908,818 shares of the business services provider’s stock worth $155,335,000 after buying an additional 1,899,515 shares in the last quarter. Vanguard Group Inc. grew its position in Rollins by 4.3% during the fourth quarter. Vanguard Group Inc. now owns 38,282,523 shares of the business services provider’s stock worth $2,297,717,000 after buying an additional 1,562,241 shares in the last quarter. USS Investment Management Ltd increased its stake in Rollins by 55.9% during the 1st quarter. USS Investment Management Ltd now owns 3,131,337 shares of the business services provider’s stock worth $167,260,000 after acquiring an additional 1,123,237 shares during the period. Finally, Bessemer Group Inc. increased its stake in Rollins by 11,772.1% during the 4th quarter. Bessemer Group Inc. now owns 1,084,398 shares of the business services provider’s stock worth $65,086,000 after acquiring an additional 1,075,264 shares during the period. Institutional investors own 51.79% of the company’s stock.

Wall Street Analysts Forecast Growth A number of brokerages recently commented on ROL. Citigroup assumed coverage on Rollins in a research report on Wednesday, July 15th. They issued a “neutral” rating and a $46.00 price target on the stock. Sanford C. Bernstein cut shares of Rollins from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $70.00 to $52.00 in a research report on Friday, May 29th. Loop Capital started coverage on shares of Rollins in a research note on Monday, April 13th. They set a “hold” rating and a $56.00 price objective on the stock. The Goldman Sachs Group reissued a “buy” rating and issued a $67.00 target price on shares of Rollins in a report on Thursday, April 23rd. Finally, UBS Group set a $50.00 target price on shares of Rollins in a research report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $60.87.

Get Our Latest Stock Report on Rollins

Rollins Stock Down 0.6% Shares of NYSE ROL opened at $44.82 on Tuesday. The company has a market cap of $21.58 billion, a price-to-earnings ratio of 41.12, a PEG ratio of 2.77 and a beta of 0.75. The company has a current ratio of 0.65, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35. Rollins, Inc. has a 12 month low of $41.50 and a 12 month high of $66.14. The stock has a 50-day moving average price of $47.05 and a two-hundred day moving average price of $54.23.

Rollins (NYSE:ROL – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The business services provider reported $0.24 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.24. The company had revenue of $906.42 million for the quarter, compared to the consensus estimate of $895.17 million. Rollins had a net margin of 13.77% and a return on equity of 38.37%. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same period last year, the company posted $0.22 EPS. As a group, analysts forecast that Rollins, Inc. will post 1.24 earnings per share for the current fiscal year.

Key Headlines Impacting Rollins Here are the key news stories impacting Rollins this week:

Positive Sentiment: Analysts expect Rollins’ second-quarter revenue and earnings to increase, supported by acquisitions, market expansion, cross-selling and pricing power. Rollins is Set to Report Q2 Earnings: Here’s What You Should Know Positive Sentiment: Another preview said investors should watch key operating metrics, signaling that results could show continued underlying business momentum. Rollins (ROL) Q2 Earnings on the Horizon: Analysts’ Insights on Key Performance Measures Neutral Sentiment: A market commentary piece said Rollins’ revenue beat and rising EPS estimates are favorable for shareholders, but it was more interpretive than a new catalyst. What Rollins (ROL)’s Revenue Beat and Rising EPS Estimates Mean For Shareholders About Rollins (Free Report)

Rollins, Inc (NYSE: ROL) is a provider of pest and termite control services operating through a network of subsidiaries and franchises. Headquartered in Atlanta, Georgia, the company offers a broad range of pest management solutions for both residential and commercial customers, positioning itself as a specialist in protecting property and public health from pests and vectors.

Its service offerings include general pest control, termite inspection and treatment, bed bug remediation, mosquito and vector control, wildlife exclusion, and related specialty services.

Featured Articles Five stocks we like better than Rollins The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Rollins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rollins and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Sells 125,721 Shares of Qualcomm Incorporated $QCOM

NEXT HEADLINE »Garrett Motion Inc. $GTX Shares Purchased by Allspring Global Investments Holdings LLC

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC cut its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 7.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 43,198 shares of the company’s stock after selling 3,332 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.05% of IDEXX Laboratories worth $24,392,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Elyxium Wealth LLC purchased a new stake in shares of IDEXX Laboratories in the 4th quarter valued at about $3,666,459,000. J. Stern & Co. LLP grew its stake in IDEXX Laboratories by 23,694.7% in the 4th quarter. J. Stern & Co. LLP now owns 2,653,351 shares of the company’s stock worth $1,795,072,000 after buying an additional 2,642,200 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in shares of IDEXX Laboratories by 63,503.9% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,444,445 shares of the company’s stock worth $977,210,000 after buying an additional 1,442,174 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of IDEXX Laboratories by 318.1% in the 4th quarter. Wellington Management Group LLP now owns 779,214 shares of the company’s stock worth $527,162,000 after buying an additional 592,834 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of IDEXX Laboratories during the 4th quarter valued at $332,265,000. 87.84% of the stock is currently owned by institutional investors.

IDEXX Laboratories Stock Down 0.6% Shares of NASDAQ:IDXX opened at $563.81 on Tuesday. The stock has a market capitalization of $44.47 billion, a P/E ratio of 41.52, a price-to-earnings-growth ratio of 3.10 and a beta of 1.55. The stock’s 50-day moving average price is $555.13 and its 200-day moving average price is $598.49. The company has a current ratio of 1.12, a quick ratio of 0.82 and a debt-to-equity ratio of 0.19. IDEXX Laboratories, Inc. has a 12-month low of $513.02 and a 12-month high of $769.98.

IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $3.47 earnings per share for the quarter, beating the consensus estimate of $3.41 by $0.06. IDEXX Laboratories had a return on equity of 70.87% and a net margin of 24.63%.The company had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.12 billion. During the same period in the prior year, the business posted $2.91 EPS. IDEXX Laboratories’s quarterly revenue was up 14.3% compared to the same quarter last year. IDEXX Laboratories has set its FY 2026 guidance at 14.450-14.900 EPS. On average, equities analysts anticipate that IDEXX Laboratories, Inc. will post 14.68 earnings per share for the current year.

Analyst Upgrades and Downgrades IDXX has been the subject of a number of research analyst reports. Weiss Ratings downgraded shares of IDEXX Laboratories from a “hold (c+)” rating to a “hold (c)” rating in a report on Tuesday, July 14th. Wall Street Zen lowered IDEXX Laboratories from a “buy” rating to a “hold” rating in a research note on Sunday, July 12th. Citigroup began coverage on IDEXX Laboratories in a report on Wednesday, April 15th. They issued a “neutral” rating and a $650.00 price objective for the company. UBS Group reduced their price objective on IDEXX Laboratories from $730.00 to $640.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 28th. Finally, Stifel Nicolaus decreased their price objective on IDEXX Laboratories from $775.00 to $675.00 and set a “buy” rating on the stock in a report on Tuesday, March 31st. Six investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $751.00.

Get Our Latest Report on IDXX

About IDEXX Laboratories (Free Report)

IDEXX Laboratories, Inc (NASDAQ: IDXX) is a global developer, manufacturer and provider of diagnostic products and services primarily for the animal health, water testing and food safety markets. Headquartered in Westbrook, Maine, the company supplies in-clinic diagnostic instruments, consumables, reference laboratory testing and practice-management tools that support veterinarians, livestock and dairy producers, and utilities and food producers worldwide.

IDEXX’s product portfolio includes point-of-care tests and immunoassays designed for rapid diagnosis in veterinary clinics, in-clinic chemistry and hematology analyzers, automated urinalysis systems, and digital diagnostic solutions.

See Also Five stocks we like better than IDEXX Laboratories The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding IDXX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report).

Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Has $23.57 Million Stock Holdings in Vanguard FTSE Europe ETF $VGK

NEXT HEADLINE »La-Z-Boy Incorporated $LZB Shares Acquired by Allspring Global Investments Holdings LLC

Key Takeaways:

Parsons delivers integrated industrial base modernization and advanced manufacturing solutions that accelerate mission readiness across defense and infrastructure markets worldwide.Parsons’ enterprise-wide delivery model unites expertise across its Federal Solutions and Critical Infrastructure segments to deliver complete industrial ecosystems at speed and scale.With global execution and proven programs, Parsons supports urgent national security and economic priorities driven by rising demand and sustained government investment in industrial capacity. CHANTILLY, Va., July 21, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) today highlighted its delivery of integrated industrial base modernization and advanced manufacturing solutions that are strengthening national security, enabling global infrastructure resilience, and accelerating delivery of mission-critical capabilities across defense and commercial markets.

As demand intensifies to modernize aging infrastructure and scale production of critical capabilities, Parsons delivers integrated, end-to-end solutions that transform how industrial capacity is built, modernized, and sustained. By combining deep engineering expertise, advanced technologies, and global program delivery, the company enables customers to expand production, strengthen supply chains, and deliver operational capability in real time.

“Industrial base modernization is no longer a future priority; it’s an immediate operational requirement,” said Martin Boson, president of Engineered Systems for Parsons. “We are helping redefine how the defense industrial base is modernized, integrating advanced manufacturing, infrastructure, and digital capabilities to rapidly scale production, improve readiness, and deliver mission-critical capacity for today’s and tomorrow’s threats.”

Parsons differentiates through a fully integrated delivery model that unifies planning, engineering, program and construction management, advanced manufacturing, cybersecurity, and environmental solutions expertise into a single approach. This enables the company to deliver complete industrial ecosystems rather than standalone facilities, accelerating timelines, reducing risk, and ensuring mission success. By leveraging capabilities across both its Federal Solutions and Critical Infrastructure segments, Parsons bridges traditionally siloed markets and delivers mission-aligned solutions at scale.

“Industrial base modernization requires more than expanding production; it demands the infrastructure, energy, and systems that sustain it,” said Mark Fialkowski, president of Infrastructure North America for Parsons. “We are delivering integrated solutions across critical infrastructure, from data centers and energy systems to industrial development, to help our customers strengthen resilience, enable economic growth, and build the industrial ecosystems needed to support both national security and commercial demands.”

Parsons’ capabilities span the full spectrum of defense industrial base modernization priorities, from modernizing Army munitions and ammunition facilities to upgrading legacy infrastructure across depots, arsenals, and manufacturing plants. This is demonstrated by the company’s growing role in the U.S. Army’s Organic Industrial Base, including a $169.5 million design-build contract with the U.S. Army Corps of Engineers to deliver a new Ammonium Nitrate Solution Tank Farm at Holston Army Ammunition Plant. The company also supports expanded production capacity through work on Nammo’s new rocket motor production facility in Perry, Florida, strengthening production scale, supply chain resilience, and operational readiness.

The company also delivers complex energetics and specialized facilities, as demonstrated by the Blue Grass Chemical Weapons Stockpile Destruction Project, where Parsons played a central role in the design, construction, operation, and closure of the facility that safely eliminated the nation’s remaining chemical weapons stockpile in support of critical national security objectives. This legacy chemical demilitarization expertise reflects Parsons’ ability to execute highly complex, high-consequence industrial programs requiring advanced safety, regulatory, environmental, and operational expertise.

Beyond the United States, Parsons is executing large-scale industrial and infrastructure programs globally. In the Middle East, the company is advancing economic diversification and industrial growth through initiatives such as the Al Karaana Special Economic Zone in Qatar. Our long record of developing large industrial cities and special economic zones in Saudi Arabia, dating back to the 1970s, such as Jazan and Yanbu Industrial Cities, enables integrated development and long-term resilience. Parsons also delivers mission-critical data center infrastructure across the region to support AI, digital transformation, and secure operations, while strengthening supply chains tied to critical minerals and advanced manufacturing.

In parallel, Parsons is advancing high-tech manufacturing ecosystems, including semiconductor-related infrastructure that strengthens domestic and allied production capacity and enables more resilient supply chains through critical minerals sourcing, processing, and distribution.

The company further integrates digital engineering, environmental remediation, and critical infrastructure protection to modernize legacy industrial sites and enable next-generation manufacturing. By combining lifecycle optimization, regulatory alignment, and mission-critical cybersecurity and physical protection, the company delivers resilient, high-performance facilities designed for sustained operations in complex and contested environments. Its program advisory expertise, including long-standing support to the Department of Energy and the Department of War, helps translate evolving mission requirements into executable infrastructure investments that strengthen the full industrial ecosystem from production through distribution.

Parsons also delivers the critical infrastructure that powers and sustains industrial capacity, including energy and microgrid solutions and industrial water and wastewater systems. In addition, the company is also advancing nuclear energy solutions critical to powering next-generation industrial capacity and strengthening energy resilience. The integrated energy capabilities are delivered across the full lifecycle, supporting both national security missions and commercial energy infrastructure, including energy-intensive industries such as advanced manufacturing and data centers.

These capabilities extend across North America, the Middle East, and other key markets, including Canada, where Parsons supports infrastructure and industrial development aligned with national growth and resource priorities. This global reach, combined with deep technical expertise, positions Parsons to deliver consistent, high-impact outcomes across diverse operational environments.

Demand for industrial base modernization continues to accelerate, driven by geopolitical competition, supply chain vulnerabilities, and significant government investment in munitions production, advanced manufacturing, and critical infrastructure. Parsons is directly aligned with these priorities, helping customers respond to urgent operational needs while building long-term resilience.

With decades of experience delivering complex industrial and infrastructure programs, Parsons continues to enable the next generation of scalable, resilient, and secure industrial capacity, delivering capability at the speed and scale today’s missions demand.

To learn more about Parsons’ industrial base modernization capabilities, visit parsons.com/industrial-base-modernization/ and parsons.com/manufacturing/.

About Parsons 

Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and global infrastructure markets, with capabilities across cyber and electronic warfare, space and missile defense, transportation, water and environment, urban development, and critical infrastructure protection. Please visit Parsons.com and follow us on LinkedIn to learn how we’re making an impact. 

Forward-Looking Statements 

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on our current expectations, beliefs and assumptions, and are not guarantees of future performance. Forward-looking statements are inherently subject to uncertainties, risks, changes in circumstances, trends and factors that are difficult to predict, many of which are outside of our control. Accordingly, actual performance, results and events may vary materially from those indicated in the forward-looking statements, and you should not rely on the forward-looking statements as predictions of future performance, results or events. Numerous factors could cause actual future performance, results and events to differ materially from those indicated in the forward-looking statements, including, among others: any issue that compromises our relationships with the U.S. federal government or its agencies or other state, local or foreign governments or agencies; any issues that damage our professional reputation; changes in governmental priorities that shift expenditures away from agencies or programs that we support; our dependence on long-term government contracts, which are subject to the government’s budgetary approval process; the size of our addressable markets and the amount of government spending on private contractors; failure by us or our employees to obtain and maintain necessary security clearances or certifications; failure to comply with numerous laws and regulations; changes in government procurement, contract or other practices or the adoption by governments of new laws, rules, regulations and programs in a manner adverse to us; the termination or nonrenewal of our government contracts, particularly our contracts with the U.S. federal government; our ability to compete effectively in the competitive bidding process and delays, contract terminations or cancellations caused by competitors’ protests of major contract awards received by us; our ability to generate revenue under certain of our contracts; any inability to attract, train or retain employees with the requisite skills, experience and security clearances; the loss of members of senior management or failure to develop new leaders; misconduct or other improper activities from our employees or subcontractors; our ability to realize the full value of our backlog and the timing of our receipt of revenue under contracts included in backlog; changes in the mix of our contracts and our ability to accurately estimate or otherwise recover expenses, time and resources for our contracts; changes in estimates used in recognizing revenue; internal system or service failures and security breaches; and inherent uncertainties and potential adverse developments in legal proceedings, including litigation, audits, reviews and investigations, which may result in materially adverse judgments, settlements or other unfavorable outcomes. These factors are not exhaustive and additional factors could adversely affect our business and financial performance. For a discussion of additional factors that could materially adversely affect our business and financial performance, see the factors included under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, and our other filings with the Securities and Exchange Commission. All forward-looking statements are based on currently available information and speak only as of the date on which they are made. We assume no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information or otherwise, except to the extent we are required to do so by law. 

Media Contact:
Bernadette Miller
+1 980.253.9781
[email protected]

Investor Relations Contact:
Dave Spille
+1 703.775.6191
[email protected]

Andra AP fonden lifted its position in shares of Amphenol Corporation (NYSE:APH – Free Report) by 96.2% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 239,588 shares of the electronics maker’s stock after buying an additional 117,453 shares during the period. Andra AP fonden’s holdings in Amphenol were worth $30,272,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Amphenol by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 126,553,498 shares of the electronics maker’s stock valued at $17,102,440,000 after buying an additional 1,322,682 shares during the period. J. Stern & Co. LLP lifted its holdings in shares of Amphenol by 9,435.8% during the 4th quarter. J. Stern & Co. LLP now owns 76,769,791 shares of the electronics maker’s stock valued at $10,374,670,000 after acquiring an additional 75,964,718 shares in the last quarter. State Street Corp boosted its position in Amphenol by 1.6% during the 4th quarter. State Street Corp now owns 56,913,598 shares of the electronics maker’s stock worth $7,705,440,000 after purchasing an additional 888,526 shares during the period. JPMorgan Chase & Co. boosted its position in Amphenol by 102.7% during the 4th quarter. JPMorgan Chase & Co. now owns 34,325,148 shares of the electronics maker’s stock worth $4,638,701,000 after purchasing an additional 17,387,536 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Amphenol by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 30,318,652 shares of the electronics maker’s stock valued at $4,087,372,000 after purchasing an additional 748,813 shares in the last quarter. Institutional investors and hedge funds own 97.01% of the company’s stock.

Amphenol Trading Down 0.5% NYSE:APH opened at $150.50 on Tuesday. The stock has a market cap of $185.15 billion, a price-to-earnings ratio of 43.25, a price-to-earnings-growth ratio of 1.29 and a beta of 1.24. Amphenol Corporation has a one year low of $95.19 and a one year high of $178.52. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.71. The business’s 50-day simple moving average is $150.36 and its 200 day simple moving average is $144.16.

Amphenol (NYSE:APH – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The electronics maker reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.11. The firm had revenue of $7.62 billion during the quarter, compared to analyst estimates of $7.08 billion. Amphenol had a return on equity of 37.44% and a net margin of 17.24%.Amphenol’s quarterly revenue was up 58.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.63 EPS. Amphenol has set its Q2 2026 guidance at 1.140-1.160 EPS. As a group, sell-side analysts predict that Amphenol Corporation will post 4.87 earnings per share for the current fiscal year.

Amphenol Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 23rd were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 23rd. Amphenol’s dividend payout ratio (DPR) is currently 28.74%.

Insider Buying and Selling at Amphenol In other news, CEO Richard Adam Norwitt sold 17,500 shares of the company’s stock in a transaction dated Tuesday, May 5th. The shares were sold at an average price of $143.21, for a total value of $2,506,175.00. Following the sale, the chief executive officer owned 1,927,507 shares in the company, valued at approximately $276,038,277.47. This represents a 0.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last ninety days, insiders have sold 130,775 shares of company stock valued at $18,709,350. 1.42% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In A number of research analysts have commented on the company. JPMorgan Chase & Co. boosted their price objective on Amphenol from $190.00 to $200.00 and gave the stock an “overweight” rating in a research note on Thursday, April 30th. Robert W. Baird set a $177.00 target price on Amphenol in a research note on Thursday, April 30th. Seaport Research Partners reissued a “buy” rating and set a $215.00 price target on shares of Amphenol in a research report on Thursday, April 30th. TD Cowen restated a “hold” rating and issued a $175.00 price target (up from $135.00) on shares of Amphenol in a report on Monday, July 13th. Finally, Jefferies Financial Group increased their price objective on shares of Amphenol from $165.00 to $190.00 and gave the company a “buy” rating in a research report on Thursday, April 30th. Fourteen equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Amphenol presently has a consensus rating of “Moderate Buy” and a consensus target price of $186.00.

Get Our Latest Stock Report on APH

Amphenol Company Profile (Free Report)

Amphenol Corporation (NYSE: APH) is a leading global manufacturer of electronic and fiber optic connectors, interconnect systems, and related components. The company designs, engineers and produces a broad range of products including electrical connectors, cable assemblies, fiber optic solutions, sensors, antennas and electromechanical devices used to transfer power, signal and data across complex systems. Its product portfolio spans ruggedized connectors for harsh environments to high-speed solutions for data centers and telecommunications networks.

Amphenol serves a diverse set of end markets, including automotive, broadband and telecom, data communications, mobile devices, industrial, energy, and military/aerospace.

Featured Articles Five stocks we like better than Amphenol The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding APH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amphenol Corporation (NYSE:APH – Free Report).

Receive News & Ratings for Amphenol Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amphenol and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. lifted its holdings in shares of Datadog, Inc. (NASDAQ:DDOG – Free Report) by 15.0% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 140,788 shares of the company’s stock after buying an additional 18,322 shares during the period. Amova Asset Management Americas Inc.’s holdings in Datadog were worth $16,616,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC bought a new stake in shares of Datadog during the fourth quarter worth $209,000. Bison Wealth LLC bought a new position in shares of Datadog in the 4th quarter valued at $228,000. Empowered Funds LLC boosted its holdings in shares of Datadog by 7.0% during the 1st quarter. Empowered Funds LLC now owns 10,313 shares of the company’s stock valued at $1,023,000 after acquiring an additional 672 shares in the last quarter. Geneos Wealth Management Inc. boosted its holdings in shares of Datadog by 17.6% during the 1st quarter. Geneos Wealth Management Inc. now owns 769 shares of the company’s stock valued at $76,000 after acquiring an additional 115 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in Datadog during the 2nd quarter worth $509,000. Institutional investors and hedge funds own 78.29% of the company’s stock.

Insider Activity In other news, Director Michael James Callahan sold 112,500 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $231.60, for a total transaction of $26,055,000.00. Following the completion of the sale, the director directly owned 14,996 shares of the company’s stock, valued at $3,473,073.60. The trade was a 88.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David M. Obstler sold 75,000 shares of the firm’s stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $231.69, for a total transaction of $17,376,750.00. Following the completion of the transaction, the chief financial officer directly owned 434,591 shares in the company, valued at approximately $100,690,388.79. The trade was a 14.72% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 1,439,533 shares of company stock valued at $323,367,430. Corporate insiders own 6.48% of the company’s stock.

Datadog News Roundup Here are the key news stories impacting Datadog this week:

Positive Sentiment: JMP Securities raised its price target to $311 from $225 and kept an Outperform-style rating, saying infrastructure software looks stronger than applications and that Datadog has been a standout performer in its coverage. Why Datadog (DDOG) Stock Is Trading Up Today Positive Sentiment: Wells Fargo increased its target to $295 from $230 and reiterated an Overweight rating, suggesting more upside from current levels. Datadog Price Target Raised by Wells Fargo Positive Sentiment: Oppenheimer lifted its target to $300 from $220 and maintained an Outperform rating, adding to the wave of upbeat analyst calls. Datadog Price Target Raised by Oppenheimer Positive Sentiment: Another report said Citizens JMP raised Datadog’s target to $311 from $225, implying further confidence in the stock’s run after its strong year-to-date performance. Datadog Price Target Raised by Citizens JMP Neutral Sentiment: One comparison piece argued that Penguin is the better AI infrastructure buy than Datadog because of faster growth, AI momentum, and a lower valuation, which may temper enthusiasm but does not appear to be a direct catalyst. PENG vs. DDOG: Which AI Infrastructure Stock Is the Better Buy Now? Datadog Stock Up 1.7% Shares of NASDAQ:DDOG opened at $263.20 on Tuesday. Datadog, Inc. has a 1 year low of $98.01 and a 1 year high of $278.70. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.40 and a quick ratio of 3.40. The business’s 50-day moving average is $237.89 and its 200-day moving average is $165.62. The company has a market capitalization of $93.69 billion, a price-to-earnings ratio of 692.65, a P/E/G ratio of 26.30 and a beta of 1.54.

Datadog (NASDAQ:DDOG – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.51 by $0.09. The business had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $960.12 million. Datadog had a return on equity of 4.83% and a net margin of 3.69%.The firm’s revenue was up 32.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.46 earnings per share. Datadog has set its FY 2026 guidance at 2.360-2.440 EPS and its Q2 2026 guidance at 0.570-0.590 EPS. Equities research analysts predict that Datadog, Inc. will post 0.64 earnings per share for the current year.

Wall Street Analyst Weigh In A number of equities analysts have issued reports on DDOG shares. Morgan Stanley raised Datadog from an “overweight” rating to an “overweight” rating in a report on Monday, June 15th. Craig Hallum started coverage on Datadog in a report on Monday, June 15th. They set a “buy” rating on the stock. Monness Crespi & Hardt upped their price objective on Datadog from $255.00 to $270.00 in a research note on Thursday, May 7th. Stifel Nicolaus set a $305.00 price objective on shares of Datadog in a report on Thursday, May 7th. Finally, Wedbush started coverage on shares of Datadog in a report on Monday, June 15th. They set a “neutral” rating on the stock. Two analysts have rated the stock with a Strong Buy rating, forty have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $256.80.

Get Our Latest Research Report on DDOG

Datadog Company Profile (Free Report)

Datadog (NASDAQ: DDOG) is a cloud-based monitoring and observability platform that helps organizations monitor, troubleshoot and secure their applications and infrastructure at scale. Its software-as-a-service offering collects and analyzes metrics, traces and logs from servers, containers, cloud services and applications to provide real-time visibility into system performance and health. Datadog’s platform is widely used by engineering, operations and security teams to reduce downtime, accelerate incident response and improve application reliability.

The company’s product suite includes infrastructure monitoring, application performance monitoring (APM), log management, real user monitoring (RUM), synthetic monitoring and network performance monitoring, along with security-focused products such as security monitoring and cloud SIEM.

Recommended Stories Five stocks we like better than Datadog The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Datadog Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Datadog and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Has $17.18 Million Holdings in Pony AI Inc. – Sponsored ADR $PONY

NEXT HEADLINE »Schrodinger, Inc. $SDGR Shares Purchased by Amova Asset Management Americas Inc.

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. lessened its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 5.3% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,853,875 shares of the company’s stock after selling 104,236 shares during the quarter. CRISPR Therapeutics comprises approximately 1.2% of Amova Asset Management Americas Inc.’s holdings, making the stock its 26th biggest holding. Amova Asset Management Americas Inc. owned approximately 1.92% of CRISPR Therapeutics worth $88,189,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in CRSP. Hollencrest Capital Management increased its holdings in shares of CRISPR Therapeutics by 249.9% during the 1st quarter. Hollencrest Capital Management now owns 1,312 shares of the company’s stock worth $62,000 after buying an additional 937 shares during the last quarter. KBC Group NV boosted its holdings in CRISPR Therapeutics by 3,999.9% in the first quarter. KBC Group NV now owns 116,847 shares of the company’s stock valued at $5,558,000 after acquiring an additional 113,997 shares during the last quarter. Swiss National Bank grew its position in CRISPR Therapeutics by 5.1% during the first quarter. Swiss National Bank now owns 169,700 shares of the company’s stock valued at $8,073,000 after acquiring an additional 8,200 shares during the period. Allspring Global Investments Holdings LLC grew its position in CRISPR Therapeutics by 11.4% during the first quarter. Allspring Global Investments Holdings LLC now owns 5,932 shares of the company’s stock valued at $290,000 after acquiring an additional 605 shares during the period. Finally, Independent Financial Group LLC acquired a new stake in CRISPR Therapeutics during the first quarter worth about $292,000. 69.20% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CRISPR Therapeutics In related news, insider Naimish Patel sold 3,786 shares of CRISPR Therapeutics stock in a transaction on Friday, May 29th. The shares were sold at an average price of $55.62, for a total transaction of $210,577.32. Following the sale, the insider owned 19,357 shares of the company’s stock, valued at $1,076,636.34. The trade was a 16.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 5.20% of the stock is owned by company insiders.

CRISPR Therapeutics Stock Down 1.7% NASDAQ CRSP opened at $46.99 on Tuesday. The company has a quick ratio of 17.96, a current ratio of 17.97 and a debt-to-equity ratio of 0.32. CRISPR Therapeutics AG has a fifty-two week low of $44.12 and a fifty-two week high of $78.48. The business has a 50 day moving average price of $52.96 and a two-hundred day moving average price of $52.88. The stock has a market cap of $4.53 billion, a PE ratio of -7.55 and a beta of 1.71.

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) last posted its quarterly earnings data on Tuesday, March 31st. The company reported ($1.28) earnings per share (EPS) for the quarter. The firm had revenue of $1.46 million for the quarter. CRISPR Therapeutics had a negative net margin of 13,856.54% and a negative return on equity of 25.66%. As a group, sell-side analysts predict that CRISPR Therapeutics AG will post -4.9 EPS for the current fiscal year.

Analysts Set New Price Targets A number of equities analysts have recently commented on the company. Wall Street Zen downgraded CRISPR Therapeutics from a “hold” rating to a “sell” rating in a report on Sunday, July 5th. Citizens Jmp reissued a “market outperform” rating and set a $80.00 target price on shares of CRISPR Therapeutics in a research report on Monday, July 6th. Weiss Ratings restated a “sell (d-)” rating on shares of CRISPR Therapeutics in a report on Friday. Evercore reaffirmed an “outperform” rating and set a $76.00 price target on shares of CRISPR Therapeutics in a research report on Monday, May 11th. Finally, UBS Group set a $80.00 price objective on shares of CRISPR Therapeutics in a research note on Friday, June 12th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, CRISPR Therapeutics currently has an average rating of “Moderate Buy” and an average target price of $67.78.

Check Out Our Latest Report on CRISPR Therapeutics

About CRISPR Therapeutics (Free Report)

CRISPR Therapeutics AG is a biopharmaceutical company specializing in the development of gene-editing therapies based on the CRISPR/Cas9 platform. The company applies its proprietary technology to modify genes in human cells, aiming to create durable treatments for a range of serious diseases. Its research and development efforts focus on both ex vivo and in vivo applications, enabling targeted correction or disruption of disease-causing genes.

Among its lead programs is CTX001, an ex vivo edited cell therapy designed to treat sickle cell disease and transfusion-dependent β-thalassemia in collaboration with Vertex Pharmaceuticals.

Featured Articles Five stocks we like better than CRISPR Therapeutics The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for CRISPR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRISPR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlTi Global Inc. Sells 1,847 Shares of Vanguard Small-Cap ETF $VB

NEXT HEADLINE »10x Genomics $TXG Shares Sold by Amova Asset Management Americas Inc.

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC lessened its holdings in shares of Wintrust Financial Corporation (NASDAQ:WTFC – Free Report) by 22.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 147,086 shares of the bank’s stock after selling 43,401 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.22% of Wintrust Financial worth $20,601,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of WTFC. Norges Bank bought a new stake in Wintrust Financial during the fourth quarter valued at approximately $111,924,000. Wellington Management Group LLP bought a new position in shares of Wintrust Financial in the 3rd quarter worth $90,187,000. Artemis Investment Management LLP bought a new position in shares of Wintrust Financial in the 4th quarter worth $59,287,000. Vaughan Nelson Investment Management L.P. purchased a new stake in shares of Wintrust Financial during the 1st quarter valued at $34,272,000. Finally, Balyasny Asset Management L.P. raised its position in shares of Wintrust Financial by 491.6% during the 4th quarter. Balyasny Asset Management L.P. now owns 254,329 shares of the bank’s stock valued at $35,560,000 after buying an additional 211,338 shares in the last quarter. Hedge funds and other institutional investors own 93.48% of the company’s stock.

Wintrust Financial Stock Performance Wintrust Financial stock opened at $163.66 on Tuesday. The company has a quick ratio of 0.97, a current ratio of 0.98 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $11.04 billion, a PE ratio of 13.72 and a beta of 0.84. The firm has a fifty day simple moving average of $155.48 and a two-hundred day simple moving average of $149.06. Wintrust Financial Corporation has a twelve month low of $119.61 and a twelve month high of $167.21.

Wintrust Financial (NASDAQ:WTFC – Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The bank reported $3.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.15. The firm had revenue of $961.41 million for the quarter, compared to analysts’ expectations of $735.36 million. Wintrust Financial had a return on equity of 13.15% and a net margin of 20.11%.During the same period last year, the firm earned $2.78 earnings per share. Research analysts expect that Wintrust Financial Corporation will post 13.03 EPS for the current year.

Wall Street Analyst Weigh In WTFC has been the subject of several research reports. Piper Sandler reiterated an “overweight” rating and issued a $188.00 target price (up from $184.00) on shares of Wintrust Financial in a research report on Wednesday, April 22nd. Weiss Ratings restated a “buy (b)” rating on shares of Wintrust Financial in a research report on Monday, June 29th. TD Cowen lifted their price target on Wintrust Financial from $173.00 to $176.00 and gave the stock a “buy” rating in a research note on Thursday, April 23rd. DA Davidson reiterated a “buy” rating and issued a $185.00 price objective on shares of Wintrust Financial in a report on Tuesday, June 30th. Finally, UBS Group reiterated a “neutral” rating and set a $170.00 price objective on shares of Wintrust Financial in a research report on Tuesday, July 7th. Ten research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $174.92.

Read Our Latest Stock Analysis on Wintrust Financial

Insider Buying and Selling In related news, CFO David L. Stoehr sold 3,020 shares of the company’s stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of $150.45, for a total transaction of $454,359.00. Following the completion of the sale, the chief financial officer directly owned 13,213 shares in the company, valued at $1,987,895.85. This represents a 18.60% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Suzet M. Mckinney sold 500 shares of the stock in a transaction on Monday, May 4th. The shares were sold at an average price of $148.96, for a total transaction of $74,480.00. Following the sale, the director directly owned 3,303 shares of the company’s stock, valued at $492,014.88. The trade was a 13.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 13,099 shares of company stock worth $1,954,386 in the last ninety days. 1.24% of the stock is owned by insiders.

Wintrust Financial Profile (Free Report)

Wintrust Financial Corporation is a Chicago‐area bank holding company headquartered in Rosemont, Illinois. Through its primary subsidiary, Wintrust Bank, the company operates a network of community banks serving metropolitan Chicago and select markets in southeastern Wisconsin. These locally branded banks provide personalized commercial and consumer banking solutions tailored to small and mid‐size businesses, professionals, and individual clients.

The firm’s core offerings include deposit products, commercial and residential lending, treasury management, and mortgage banking services.

Further Reading Five stocks we like better than Wintrust Financial The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Wintrust Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wintrust Financial and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlpha Zero LLC Has $10.73 Million Position in Invesco S&P 500 Momentum ETF $SPMO

NEXT HEADLINE »Schwab US Large-Cap ETF $SCHX Holdings Boosted by Alpha Zero LLC

Posted by Defense World Staff on Jul 21st, 2026

Andra AP fonden boosted its position in shares of Arista Networks, Inc. (NYSE:ANET – Free Report) by 22.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 250,000 shares of the technology company’s stock after purchasing an additional 46,000 shares during the quarter. Andra AP fonden’s holdings in Arista Networks were worth $30,695,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Intrua Financial LLC lifted its stake in shares of Arista Networks by 2.7% in the first quarter. Intrua Financial LLC now owns 2,307 shares of the technology company’s stock worth $283,000 after buying an additional 61 shares in the last quarter. NBT Bank N A NY increased its position in shares of Arista Networks by 37.2% during the first quarter. NBT Bank N A NY now owns 247 shares of the technology company’s stock valued at $30,000 after acquiring an additional 67 shares in the last quarter. Hoxton Planning & Management LLC raised its holdings in Arista Networks by 4.1% in the 1st quarter. Hoxton Planning & Management LLC now owns 1,744 shares of the technology company’s stock worth $214,000 after acquiring an additional 68 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its position in Arista Networks by 0.4% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 16,085 shares of the technology company’s stock valued at $2,133,000 after acquiring an additional 70 shares in the last quarter. Finally, Y.D. More Investments Ltd lifted its position in Arista Networks by 8.7% in the 1st quarter. Y.D. More Investments Ltd now owns 870 shares of the technology company’s stock valued at $107,000 after acquiring an additional 70 shares in the last quarter. 82.47% of the stock is currently owned by institutional investors.

Insider Transactions at Arista Networks In related news, CEO Jayshree Ullal sold 234,578 shares of the business’s stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $187.18, for a total value of $43,908,310.04. Following the sale, the chief executive officer directly owned 5,134,207 shares in the company, valued at approximately $961,020,866.26. The trade was a 4.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Andreas Bechtolsheim sold 240,000 shares of the stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $162.67, for a total value of $39,040,800.00. Following the transaction, the insider directly owned 182,043,048 shares of the company’s stock, valued at approximately $29,612,942,618.16. The trade was a 0.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 2,692,983 shares of company stock valued at $452,119,385. 2.70% of the stock is owned by company insiders.

Arista Networks Stock Performance Shares of NYSE:ANET opened at $169.17 on Tuesday. The firm has a market cap of $213.02 billion, a price-to-earnings ratio of 57.94, a P/E/G ratio of 2.59 and a beta of 1.60. The firm has a fifty day moving average price of $162.41 and a 200 day moving average price of $147.60. Arista Networks, Inc. has a fifty-two week low of $106.99 and a fifty-two week high of $189.82.

Arista Networks (NYSE:ANET – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The technology company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.06. The company had revenue of $2.71 billion for the quarter, compared to the consensus estimate of $2.62 billion. Arista Networks had a net margin of 38.32% and a return on equity of 30.10%. Arista Networks’s revenue for the quarter was up 35.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.65 EPS. Arista Networks has set its Q2 2026 guidance at 0.880-0.880 EPS. As a group, research analysts predict that Arista Networks, Inc. will post 3.28 earnings per share for the current year.

Analyst Ratings Changes ANET has been the subject of several recent analyst reports. Wolfe Research restated an “outperform” rating and issued a $175.00 price target on shares of Arista Networks in a research note on Wednesday, June 10th. Citigroup reduced their price objective on Arista Networks from $176.00 to $173.00 and set a “buy” rating for the company in a report on Wednesday, May 6th. Truist Financial set a $175.00 target price on shares of Arista Networks in a research note on Wednesday, May 6th. Barclays reaffirmed an “overweight” rating and set a $195.00 price target (up from $184.00) on shares of Arista Networks in a report on Thursday, May 7th. Finally, UBS Group reaffirmed a “buy” rating and issued a $187.00 target price (up from $177.00) on shares of Arista Networks in a research report on Wednesday, May 6th. Two analysts have rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $188.95.

Check Out Our Latest Research Report on ANET

Arista Networks Profile (Free Report)

Arista Networks, Inc is a technology company that designs and sells cloud networking solutions for large-scale data centers and enterprise environments. The company is best known for its high-performance switching and routing platforms, which are used to build scalable, low-latency networks for cloud service providers, internet companies, financial services, telecommunications, and enterprise IT. Arista’s offerings emphasize programmability, automation and telemetry to support modern, software-driven network architectures.

Central to Arista’s product portfolio is its Extensible Operating System (EOS), a modular network operating system that provides consistent programmability, stateful control and advanced visibility across the company’s hardware platforms.

Featured Articles Five stocks we like better than Arista Networks The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Arista Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arista Networks and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAndra AP fonden Has $43.84 Million Stock Holdings in Merck & Co., Inc. $MRK

NEXT HEADLINE »Procter & Gamble Company (The) $PG Shares Purchased by Andra AP fonden

Allspring Global Investments Holdings LLC cut its stake in Sempra Energy (NYSE:SRE – Free Report) by 6.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 212,027 shares of the utilities provider’s stock after selling 14,131 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Sempra Energy were worth $20,654,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in SRE. Vanguard Group Inc. grew its stake in Sempra Energy by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 76,734,070 shares of the utilities provider’s stock valued at $6,774,907,000 after acquiring an additional 1,008,476 shares in the last quarter. State Street Corp lifted its stake in Sempra Energy by 5.2% in the 4th quarter. State Street Corp now owns 36,810,449 shares of the utilities provider’s stock worth $3,273,460,000 after purchasing an additional 1,824,280 shares in the last quarter. Morgan Stanley boosted its holdings in Sempra Energy by 17.0% in the 4th quarter. Morgan Stanley now owns 22,330,091 shares of the utilities provider’s stock valued at $1,971,524,000 after purchasing an additional 3,250,783 shares during the period. Geode Capital Management LLC grew its position in shares of Sempra Energy by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 14,298,845 shares of the utilities provider’s stock valued at $1,256,592,000 after purchasing an additional 116,554 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Sempra Energy by 16.6% during the 4th quarter. JPMorgan Chase & Co. now owns 12,163,523 shares of the utilities provider’s stock valued at $1,073,918,000 after purchasing an additional 1,735,516 shares in the last quarter. Hedge funds and other institutional investors own 89.65% of the company’s stock.

Analyst Upgrades and Downgrades SRE has been the topic of a number of research analyst reports. BMO Capital Markets decreased their target price on Sempra Energy from $105.00 to $103.00 and set an “outperform” rating on the stock in a research note on Monday, May 11th. Wall Street Zen lowered Sempra Energy from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. TD Cowen initiated coverage on shares of Sempra Energy in a research report on Wednesday, July 8th. They issued a “buy” rating on the stock. Morgan Stanley reiterated an “overweight” rating and set a $105.00 target price on shares of Sempra Energy in a research report on Wednesday, June 24th. Finally, Barclays cut their price target on shares of Sempra Energy from $105.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $104.08.

Get Our Latest Analysis on SRE

Sempra Energy Trading Down 1.6% SRE stock opened at $90.75 on Tuesday. The company has a market capitalization of $59.33 billion, a PE ratio of 30.76, a price-to-earnings-growth ratio of 2.22 and a beta of 0.56. Sempra Energy has a one year low of $77.87 and a one year high of $101.04. The company’s 50 day moving average price is $91.90 and its two-hundred day moving average price is $92.33. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.66 and a current ratio of 1.69.

Sempra Energy (NYSE:SRE – Get Free Report) last released its earnings results on Thursday, May 7th. The utilities provider reported $1.51 EPS for the quarter, meeting the consensus estimate of $1.51. The company had revenue of $3.65 billion for the quarter, compared to analyst estimates of $4.10 billion. Sempra Energy had a net margin of 14.31% and a return on equity of 8.20%. The firm’s quarterly revenue was down 3.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.44 EPS. Sempra Energy has set its FY 2027 guidance at 5.100-5.700 EPS and its FY 2026 guidance at 4.870-5.370 EPS. As a group, analysts predict that Sempra Energy will post 5.12 earnings per share for the current fiscal year.

Sempra Energy Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Thursday, June 25th were issued a $0.6575 dividend. This represents a $2.63 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, June 25th. Sempra Energy’s dividend payout ratio (DPR) is 89.15%.

Insider Activity at Sempra Energy In related news, EVP Caroline Ann Winn sold 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 17th. The stock was sold at an average price of $90.55, for a total transaction of $724,400.00. Following the completion of the transaction, the executive vice president owned 25,164 shares in the company, valued at $2,278,600.20. This represents a 24.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Diana L. Day sold 3,300 shares of the firm’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $92.13, for a total transaction of $304,029.00. Following the completion of the sale, the insider owned 22,870 shares of the company’s stock, valued at $2,107,013.10. This trade represents a 12.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,900 shares of company stock worth $1,261,207 in the last 90 days. Company insiders own 0.31% of the company’s stock.

Sempra Energy Profile (Free Report)

Sempra Energy is a San Diego–based energy infrastructure company that develops, owns and operates businesses delivering electricity and natural gas. Its operations include regulated utility services that provide electric and gas distribution to residential, commercial and industrial customers, as well as non‑regulated infrastructure businesses that develop and manage large-scale energy assets.

The company’s product and service portfolio spans electricity and natural gas delivery, transmission and storage, liquefied natural gas (LNG) facilities, power generation and electric transmission projects.

Further Reading Five stocks we like better than Sempra Energy The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding SRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sempra Energy (NYSE:SRE – Free Report).

Receive News & Ratings for Sempra Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sempra Energy and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. increased its holdings in shares of DoorDash, Inc. (NASDAQ:DASH – Free Report) by 6.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 252,253 shares of the company’s stock after acquiring an additional 15,929 shares during the quarter. Amova Asset Management Americas Inc. owned approximately 0.06% of DoorDash worth $37,861,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. CYBER HORNET ETFs LLC boosted its position in DoorDash by 6.5% during the 4th quarter. CYBER HORNET ETFs LLC now owns 979 shares of the company’s stock valued at $222,000 after purchasing an additional 60 shares during the period. Vise Technologies Inc. grew its position in shares of DoorDash by 1.8% during the fourth quarter. Vise Technologies Inc. now owns 3,517 shares of the company’s stock worth $796,000 after acquiring an additional 63 shares during the last quarter. MassMutual Private Wealth & Trust FSB grew its position in shares of DoorDash by 7.0% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 982 shares of the company’s stock worth $222,000 after acquiring an additional 64 shares during the last quarter. Sunbelt Securities Inc. increased its holdings in shares of DoorDash by 124.1% in the 3rd quarter. Sunbelt Securities Inc. now owns 121 shares of the company’s stock worth $33,000 after acquiring an additional 67 shares during the period. Finally, AXS Investments LLC increased its holdings in shares of DoorDash by 1.3% in the 4th quarter. AXS Investments LLC now owns 5,438 shares of the company’s stock worth $1,232,000 after acquiring an additional 69 shares during the period. Institutional investors own 90.64% of the company’s stock.

Analyst Upgrades and Downgrades Several analysts recently weighed in on DASH shares. Wedbush began coverage on shares of DoorDash in a research report on Thursday, July 16th. They issued a “neutral” rating and a $205.00 price objective on the stock. Jefferies Financial Group raised their price target on shares of DoorDash from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. UBS Group lifted their price target on DoorDash from $206.00 to $214.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Susquehanna decreased their price objective on DoorDash from $250.00 to $225.00 and set a “positive” rating for the company in a report on Friday, May 8th. Finally, Needham & Company LLC restated a “buy” rating and issued a $265.00 target price on shares of DoorDash in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, twenty-four have assigned a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.89.

View Our Latest Analysis on DASH

Insider Transactions at DoorDash In other news, Director Andy Fang sold 5,000 shares of the firm’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $180.00, for a total transaction of $900,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Ravi Inukonda sold 19,095 shares of the firm’s stock in a transaction dated Wednesday, July 8th. The shares were sold at an average price of $188.04, for a total value of $3,590,623.80. Following the transaction, the chief financial officer owned 252,443 shares in the company, valued at approximately $47,469,381.72. This trade represents a 7.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 74,927 shares of company stock valued at $13,241,532. Corporate insiders own 5.83% of the company’s stock.

DoorDash Stock Up 2.7% DASH stock opened at $189.02 on Tuesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.43 and a quick ratio of 1.43. The firm has a market capitalization of $82.36 billion, a P/E ratio of 90.01 and a beta of 1.78. DoorDash, Inc. has a 52-week low of $143.30 and a 52-week high of $285.50. The company’s 50 day simple moving average is $170.39 and its 200-day simple moving average is $177.02.

DoorDash (NASDAQ:DASH – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.06. The firm had revenue of $4.04 billion during the quarter, compared to analyst estimates of $4.15 billion. DoorDash had a net margin of 6.29% and a return on equity of 9.58%. The company’s revenue was up 33.1% on a year-over-year basis. During the same quarter last year, the business posted $0.44 EPS. As a group, equities research analysts anticipate that DoorDash, Inc. will post 2.39 EPS for the current year.

DoorDash Profile (Free Report)

DoorDash, Inc operates a technology-driven logistics and food-delivery marketplace that connects consumers, merchants and independent delivery contractors. The company’s core service enables customers to order from local restaurants and retailers through its app and website while DoorDash handles last-mile fulfillment via its network of drivers, known as “Dashers.” Over time the platform has broadened beyond restaurant deliveries to include groceries, convenience items and retail deliveries, positioning DoorDash as a broader on-demand logistics provider for consumer goods.

In addition to its marketplace, DoorDash offers a suite of products and services for consumers and businesses.

Further Reading Five stocks we like better than DoorDash The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for DoorDash Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DoorDash and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Has $24.91 Million Stake in Futu Holdings Limited Sponsored ADR $FUTU

NEXT HEADLINE »Amova Asset Management Americas Inc. Increases Position in CareDx, Inc. $CDNA

Posted by Defense World Staff on Jul 21st, 2026

MGP Ingredients, Inc. (NASDAQ:MGPI – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $20.03 and traded as low as $17.73. MGP Ingredients shares last traded at $18.21, with a volume of 144,624 shares.

Analyst Upgrades and Downgrades Several analysts have weighed in on MGPI shares. TD Cowen lowered their price target on MGP Ingredients from $20.00 to $18.00 and set a “hold” rating on the stock in a report on Friday, June 26th. Weiss Ratings lowered MGP Ingredients from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, May 4th. Zacks Research upgraded shares of MGP Ingredients from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Finally, Wells Fargo & Company lowered their target price on shares of MGP Ingredients from $24.00 to $21.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 8th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $26.50.

Get Our Latest Stock Report on MGP Ingredients

MGP Ingredients Stock Up 2.0% The company has a current ratio of 2.74, a quick ratio of 0.56 and a debt-to-equity ratio of 0.41. The firm has a market capitalization of $389.15 million, a P/E ratio of -1.63 and a beta of 0.46. The company’s fifty day simple moving average is $17.16 and its 200 day simple moving average is $20.03.

MGP Ingredients (NASDAQ:MGPI – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. MGP Ingredients had a negative net margin of 45.70% and a positive return on equity of 7.48%. The firm had revenue of $106.43 million for the quarter, compared to analyst estimates of $105.32 million. During the same quarter in the previous year, the firm posted $0.36 EPS. The company’s revenue for the quarter was down 12.5% compared to the same quarter last year. MGP Ingredients has set its FY 2026 guidance at 1.500-1.800 EPS. Research analysts expect that MGP Ingredients, Inc. will post 1.6 EPS for the current year.

MGP Ingredients Announces Dividend The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a dividend of $0.12 per share. The ex-dividend date was Friday, May 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.6%. MGP Ingredients’s dividend payout ratio is -4.31%.

Insider Activity In other news, major shareholder Caroline Lux Kaplan sold 30,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $17.82, for a total value of $534,600.00. Following the completion of the transaction, the insider owned 500,958 shares in the company, valued at $8,927,071.56. This trade represents a 5.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 31.70% of the company’s stock.

Institutional Inflows and Outflows A number of large investors have recently added to or reduced their stakes in the stock. Tieton Capital Management LLC purchased a new position in MGP Ingredients in the 4th quarter worth about $5,998,000. Pacer Advisors Inc. purchased a new stake in shares of MGP Ingredients during the 4th quarter valued at about $2,278,000. Peregrine Capital Management LLC purchased a new stake in shares of MGP Ingredients during the 4th quarter valued at about $3,606,000. Dana Investment Advisors Inc. bought a new stake in shares of MGP Ingredients in the fourth quarter worth approximately $5,348,000. Finally, Unison Advisors LLC purchased a new position in shares of MGP Ingredients during the fourth quarter valued at approximately $719,000. Hedge funds and other institutional investors own 77.11% of the company’s stock.

About MGP Ingredients (Get Free Report)

MGP Ingredients, Inc (NASDAQ: MGPI) is a leading producer of distilled spirits and specialty ingredient solutions for the food, beverage and consumer products industries. Headquartered in Atchison, Kansas, the company operates two main facilities—its historic Atchison plant, founded in 1941 as Midwest Grain Products, and a modern distillery in Lawrenceburg, Indiana. MGP Ingredients supplies an array of distillation products under its beverage and ingredient segments, serving brand owners, private-label producers and co-packers worldwide.

The beverage segment features a broad portfolio of premium spirits, including bourbon and rye whiskies, vodka, gin and neutral spirits.

See Also Five stocks we like better than MGP Ingredients The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Receive News & Ratings for MGP Ingredients Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MGP Ingredients and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEPedevco (NYSEAMERICAN:PED) Share Price Passes Below 200 Day Moving Average – Here’s Why

NEXT HEADLINE »BNY Mellon Strategic Municipals (NYSE:LEO) Shares Cross Below Two Hundred Day Moving Average – Time to Sell?

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. lowered its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 13.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,825,585 shares of the company’s stock after selling 583,715 shares during the quarter. Beam Therapeutics makes up 1.3% of Amova Asset Management Americas Inc.’s investment portfolio, making the stock its 24th largest holding. Amova Asset Management Americas Inc. owned about 3.72% of Beam Therapeutics worth $91,164,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of BEAM. Hollencrest Capital Management purchased a new stake in shares of Beam Therapeutics in the 1st quarter valued at approximately $43,000. Bank Julius Baer & Co. Ltd Zurich acquired a new position in Beam Therapeutics in the 4th quarter worth approximately $47,000. Larson Financial Group LLC grew its position in Beam Therapeutics by 4,370.5% during the 3rd quarter. Larson Financial Group LLC now owns 1,967 shares of the company’s stock worth $48,000 after purchasing an additional 1,923 shares in the last quarter. Van ECK Associates Corp grew its position in Beam Therapeutics by 48.7% during the 3rd quarter. Van ECK Associates Corp now owns 2,158 shares of the company’s stock worth $52,000 after purchasing an additional 707 shares in the last quarter. Finally, Kestra Advisory Services LLC acquired a new stake in Beam Therapeutics during the 4th quarter valued at $59,000. Institutional investors and hedge funds own 99.68% of the company’s stock.

Insider Buying and Selling In other news, insider Fmr Llc sold 251,488 shares of the stock in a transaction on Friday, June 26th. The shares were sold at an average price of $35.26, for a total transaction of $8,867,466.88. Following the transaction, the insider owned 854,583 shares in the company, valued at $30,132,596.58. This represents a 22.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.80% of the stock is owned by corporate insiders.

Beam Therapeutics Stock Down 4.4% BEAM opened at $26.33 on Tuesday. Beam Therapeutics Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $38.26. The business has a 50-day moving average of $31.47 and a 200-day moving average of $29.31. The company has a debt-to-equity ratio of 0.09, a current ratio of 16.99 and a quick ratio of 16.99. The company has a market capitalization of $2.71 billion, a PE ratio of -38.72 and a beta of 2.18.

Beam Therapeutics (NASDAQ:BEAM – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.91) EPS for the quarter, beating the consensus estimate of ($1.03) by $0.12. The business had revenue of $31.74 million during the quarter, compared to analysts’ expectations of $10.98 million. Beam Therapeutics had a negative return on equity of 29.00% and a negative net margin of 39.66%.The firm’s quarterly revenue was up 323.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($1.23) EPS. Equities research analysts forecast that Beam Therapeutics Inc. will post -4.16 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth Several analysts have recently commented on BEAM shares. Citigroup raised their target price on Beam Therapeutics from $64.00 to $68.00 and gave the stock a “buy” rating in a research report on Thursday, March 26th. Sanford C. Bernstein dropped their price target on Beam Therapeutics from $40.00 to $39.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. HC Wainwright reissued a “buy” rating and issued a $80.00 price objective on shares of Beam Therapeutics in a research note on Tuesday, July 7th. Bank of America restated a “buy” rating and set a $47.00 price objective on shares of Beam Therapeutics in a research report on Wednesday, July 8th. Finally, Tudor Pickering set a $39.00 target price on Beam Therapeutics in a report on Wednesday, May 13th. Ten research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $46.85.

View Our Latest Research Report on BEAM

About Beam Therapeutics (Free Report)

Beam Therapeutics, Inc (NASDAQ: BEAM) is a biotechnology company dedicated to developing precision genetic medicines through its pioneering base editing platform. Headquartered in Cambridge, Massachusetts, with additional research facilities in Philadelphia, the company focuses on engineering molecular editors capable of making precise single-nucleotide changes in DNA. By harnessing its proprietary base editing technology, Beam aims to correct or disrupt disease-causing genetic variants at their source, offering the potential for novel therapies in areas with significant unmet medical need.

Founded in 2017 as a spin-out from Harvard University and the Broad and Whitehead Institutes, Beam was co-founded by leading academic researcher David R.

Featured Articles Five stocks we like better than Beam Therapeutics The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Beam Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beam Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDeere & Company $DE Shares Sold by AlTi Global Inc.

NEXT HEADLINE »10,396 Shares in Akamai Technologies, Inc. $AKAM Acquired by AlTi Global Inc.

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC reduced its stake in shares of Chewy (NYSE:CHWY – Free Report) by 22.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 901,118 shares of the company’s stock after selling 254,811 shares during the period. Allspring Global Investments Holdings LLC owned 0.22% of Chewy worth $23,988,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CHWY. CoreCap Advisors LLC raised its position in shares of Chewy by 306.2% during the fourth quarter. CoreCap Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after acquiring an additional 637 shares during the last quarter. Harbour Investments Inc. boosted its holdings in Chewy by 81.4% in the fourth quarter. Harbour Investments Inc. now owns 907 shares of the company’s stock valued at $30,000 after acquiring an additional 407 shares during the last quarter. Osterweis Capital Management Inc. bought a new stake in Chewy in the second quarter valued at approximately $30,000. Los Angeles Capital Management LLC acquired a new stake in Chewy during the 4th quarter valued at approximately $31,000. Finally, Modus Advisors LLC acquired a new stake in Chewy during the 4th quarter valued at approximately $34,000. 93.09% of the stock is owned by institutional investors and hedge funds.

Chewy Trading Up 5.0% NYSE:CHWY opened at $21.98 on Tuesday. Chewy has a 12 month low of $17.40 and a 12 month high of $43.50. The stock has a market capitalization of $9.00 billion, a price-to-earnings ratio of 36.64, a PEG ratio of 1.06 and a beta of 1.45. The firm has a fifty day simple moving average of $20.34 and a two-hundred day simple moving average of $24.94.

Insider Transactions at Chewy In related news, CEO Sumit Singh sold 83,306 shares of the company’s stock in a transaction that occurred on Monday, May 4th. The stock was sold at an average price of $25.60, for a total transaction of $2,132,633.60. Following the transaction, the chief executive officer directly owned 874,061 shares of the company’s stock, valued at approximately $22,375,961.60. This represents a 8.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Da-Wai Hu sold 4,203 shares of the stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $19.49, for a total value of $81,916.47. Following the completion of the transaction, the general counsel owned 4,103 shares in the company, valued at approximately $79,967.47. The trade was a 50.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 91,729 shares of company stock worth $2,322,582 in the last three months. Insiders own 0.34% of the company’s stock.

Analyst Ratings Changes A number of brokerages have recently issued reports on CHWY. Needham & Company LLC restated a “hold” rating on shares of Chewy in a research report on Thursday, June 11th. Wedbush decreased their price objective on shares of Chewy from $42.00 to $36.00 and set an “outperform” rating for the company in a research report on Thursday, March 26th. Guggenheim reissued a “buy” rating and set a $45.00 target price on shares of Chewy in a research note on Monday, April 27th. Citizens Jmp dropped their target price on shares of Chewy from $45.00 to $28.00 and set a “market outperform” rating on the stock in a report on Thursday, June 11th. Finally, Argus raised shares of Chewy to a “strong-buy” rating in a research report on Tuesday, April 7th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $32.05.

View Our Latest Analysis on Chewy

Chewy Company Profile (Free Report)

Chewy, Inc (NYSE: CHWY) is a leading e-commerce retailer specializing in pet food, supplies and services. The company offers a comprehensive assortment of products for dogs, cats, fish, birds and other small animals, including prescription medications, veterinary health products, grooming essentials and toys. Through its online platform and mobile app, Chewy provides an intuitive shopping experience with features such as Autoship, ensuring regular deliveries of pet essentials at schedule intervals.

Founded in 2011 by Ryan Cohen and Michael Day, Chewy initially operated under the name Mr.

Further Reading Five stocks we like better than Chewy The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding CHWY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chewy (NYSE:CHWY – Free Report).

Receive News & Ratings for Chewy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chewy and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Purchases Shares of 455,446 Twist Bioscience Corporation $TWST

NEXT HEADLINE »Allspring Global Investments Holdings LLC Lowers Position in HealthEquity, Inc. $HQY

Posted by Defense World Staff on Jul 21st, 2026

AlTi Global Inc. acquired a new stake in Church & Dwight Co., Inc. (NYSE:CHD – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 18,375 shares of the company’s stock, valued at approximately $1,715,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Walter Public Investments Inc. purchased a new stake in shares of Church & Dwight in the 1st quarter worth about $5,721,000. Swiss Life Asset Management Ltd increased its position in shares of Church & Dwight by 122.6% during the fourth quarter. Swiss Life Asset Management Ltd now owns 141,837 shares of the company’s stock valued at $11,893,000 after buying an additional 78,107 shares during the period. Tandem Investment Advisors Inc. raised its stake in Church & Dwight by 11.6% in the fourth quarter. Tandem Investment Advisors Inc. now owns 797,733 shares of the company’s stock worth $66,890,000 after buying an additional 82,833 shares in the last quarter. Amiral Gestion bought a new position in Church & Dwight in the fourth quarter worth about $6,258,000. Finally, Chesley Taft & Associates LLC lifted its holdings in Church & Dwight by 12.1% in the fourth quarter. Chesley Taft & Associates LLC now owns 98,894 shares of the company’s stock worth $8,292,000 after buying an additional 10,650 shares during the period. Institutional investors own 86.60% of the company’s stock.

Insiders Place Their Bets In other Church & Dwight news, Director Penry W. Price sold 5,960 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $94.86, for a total transaction of $565,365.60. Following the completion of the sale, the director directly owned 30,070 shares in the company, valued at approximately $2,852,440.20. The trade was a 16.54% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brian D. Buchert sold 10,160 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $98.14, for a total value of $997,102.40. Following the completion of the transaction, the executive vice president directly owned 1,286 shares in the company, valued at approximately $126,208.04. This represents a 88.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 47,680 shares of company stock worth $4,672,190 in the last 90 days. Insiders own 1.20% of the company’s stock.

Wall Street Analysts Forecast Growth Several analysts have weighed in on CHD shares. Weiss Ratings raised Church & Dwight from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday. Barclays decreased their target price on Church & Dwight from $85.00 to $80.00 and set an “underweight” rating for the company in a research report on Tuesday, April 14th. JPMorgan Chase & Co. raised their target price on Church & Dwight from $99.00 to $105.00 and gave the company a “neutral” rating in a research note on Thursday, July 16th. Royal Bank Of Canada restated an “outperform” rating and set a $114.00 price target on shares of Church & Dwight in a research report on Monday, June 1st. Finally, Wall Street Zen raised Church & Dwight from a “sell” rating to a “hold” rating in a research note on Saturday, June 13th. Nine analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $103.47.

Get Our Latest Stock Analysis on CHD

Church & Dwight Stock Down 0.3% CHD stock opened at $97.76 on Tuesday. The stock has a market capitalization of $23.16 billion, a P/E ratio of 32.16, a P/E/G ratio of 3.53 and a beta of 0.47. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.22 and a quick ratio of 0.81. Church & Dwight Co., Inc. has a 1-year low of $81.33 and a 1-year high of $106.04. The business has a fifty day moving average price of $96.67 and a 200-day moving average price of $95.83.

Church & Dwight (NYSE:CHD – Get Free Report) last released its quarterly earnings data on Friday, May 1st. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.93 by $0.02. The company had revenue of $1.47 billion for the quarter, compared to analysts’ expectations of $1.46 billion. Church & Dwight had a return on equity of 20.51% and a net margin of 11.81%.Church & Dwight’s revenue was up .1% compared to the same quarter last year. During the same period last year, the firm posted $0.91 earnings per share. Church & Dwight has set its Q2 2026 guidance at 0.880-0.880 EPS and its FY 2026 guidance at 3.710-3.810 EPS. Equities analysts forecast that Church & Dwight Co., Inc. will post 3.74 earnings per share for the current fiscal year.

Church & Dwight Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were given a $0.3075 dividend. This represents a $1.23 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Friday, May 15th. Church & Dwight’s payout ratio is 40.46%.

About Church & Dwight (Free Report)

Church & Dwight Co, Inc is a U.S.-based consumer products company best known for its Arm & Hammer baking soda business. Founded in 1846 with the manufacture and marketing of sodium bicarbonate, the company has grown into a diversified maker and marketer of household, personal care and specialty products. Church & Dwight is publicly traded on the New York Stock Exchange under the ticker CHD and is headquartered in Ewing, New Jersey.

The company’s portfolio spans a range of categories including household cleaning and laundry, oral care, personal care, sexual wellness and health & wellness.

Read More Five stocks we like better than Church & Dwight The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Church & Dwight Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Church & Dwight and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE10,396 Shares in Akamai Technologies, Inc. $AKAM Acquired by AlTi Global Inc.

NEXT HEADLINE »Amova Asset Management Americas Inc. Has $84.69 Million Stake in Natera, Inc. $NTRA

Posted by Defense World Staff on Jul 21st, 2026

AlTi Global Inc. bought a new position in shares of Golub Capital BDC, Inc. (NASDAQ:GBDC – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 96,554 shares of the investment management company’s stock, valued at approximately $1,222,000.

Several other large investors have also added to or reduced their stakes in GBDC. Main Street Group LTD bought a new stake in shares of Golub Capital BDC during the first quarter valued at approximately $47,000. Fifth Third Bancorp bought a new stake in shares of Golub Capital BDC in the first quarter worth about $68,000. Advisory Services Network LLC bought a new stake in shares of Golub Capital BDC in the third quarter worth about $77,000. Clearstead Advisors LLC lifted its position in shares of Golub Capital BDC by 48.6% in the fourth quarter. Clearstead Advisors LLC now owns 5,933 shares of the investment management company’s stock worth $81,000 after buying an additional 1,941 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its position in shares of Golub Capital BDC by 104.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 6,447 shares of the investment management company’s stock worth $87,000 after buying an additional 3,287 shares in the last quarter. Hedge funds and other institutional investors own 42.38% of the company’s stock.

Analysts Set New Price Targets GBDC has been the subject of several research analyst reports. Wall Street Zen cut Golub Capital BDC from a “hold” rating to a “sell” rating in a report on Sunday, April 19th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Golub Capital BDC in a report on Wednesday, June 24th. Oppenheimer reiterated an “outperform” rating and set a $14.00 target price on shares of Golub Capital BDC in a research report on Wednesday, May 6th. Zacks Research raised shares of Golub Capital BDC from a “strong sell” rating to a “hold” rating in a report on Monday, July 6th. Finally, Royal Bank Of Canada reduced their price target on shares of Golub Capital BDC from $15.00 to $14.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $14.00.

View Our Latest Stock Report on GBDC

Golub Capital BDC Price Performance NASDAQ:GBDC opened at $12.95 on Tuesday. The firm has a market capitalization of $3.37 billion, a price-to-earnings ratio of 16.82 and a beta of 0.39. The company has a debt-to-equity ratio of 1.25, a current ratio of 2.20 and a quick ratio of 2.20. The business has a 50 day simple moving average of $12.91 and a 200-day simple moving average of $12.93. Golub Capital BDC, Inc. has a 1 year low of $11.77 and a 1 year high of $15.55.

Golub Capital BDC (NASDAQ:GBDC – Get Free Report) last released its earnings results on Monday, May 4th. The investment management company reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.02). The company had revenue of ($5.28) million for the quarter, compared to the consensus estimate of $201.71 million. Golub Capital BDC had a net margin of 24.64% and a return on equity of 10.20%. During the same period in the prior year, the firm posted $0.30 EPS. Equities analysts forecast that Golub Capital BDC, Inc. will post 1.36 EPS for the current year.

Golub Capital BDC Dividend Announcement The company also recently disclosed a quarterly dividend, which was paid on Monday, June 29th. Investors of record on Monday, June 15th were given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 10.2%. The ex-dividend date of this dividend was Monday, June 15th. Golub Capital BDC’s dividend payout ratio is 171.43%.

Golub Capital BDC Company Profile (Free Report)

Golub Capital BDC (NASDAQ: GBDC) is a publicly traded business development company specializing in providing debt and equity financing solutions to middle-market companies in the United States. Externally managed by Golub Capital LLC, the firm focuses on building a diversified portfolio of senior secured loans, unitranche facilities and second-lien debt instruments designed to support growth, acquisitions and recapitalizations. As a closed-end investment vehicle, GBDC offers investors direct exposure to private credit strategies within a regulated structure.

The company’s core business activities center on originating and managing bespoke financing arrangements for U.S.

Further Reading Five stocks we like better than Golub Capital BDC The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding GBDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Golub Capital BDC, Inc. (NASDAQ:GBDC – Free Report).

Receive News & Ratings for Golub Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Golub Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmova Asset Management Americas Inc. Has $105.78 Million Stock Position in Taiwan Semiconductor Manufacturing Company Ltd. $TSM

NEXT HEADLINE »AlTi Global Inc. Makes New Investment in Establishment Labs Holdings Inc. $ESTA

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. raised its holdings in shares of Joby Aviation, Inc. (NYSE:JOBY – Free Report) by 48.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,678,495 shares of the company’s stock after purchasing an additional 870,244 shares during the quarter. Amova Asset Management Americas Inc. owned approximately 0.27% of Joby Aviation worth $22,124,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Fifth Third Bancorp grew its position in shares of Joby Aviation by 207.4% in the fourth quarter. Fifth Third Bancorp now owns 1,998 shares of the company’s stock valued at $26,000 after purchasing an additional 1,348 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in Joby Aviation by 284.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,540 shares of the company’s stock worth $27,000 after buying an additional 1,880 shares during the period. Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new stake in shares of Joby Aviation during the fourth quarter worth $28,000. Pandora Wealth Inc. bought a new stake in shares of Joby Aviation in the fourth quarter valued at about $32,000. Finally, DV Equities LLC acquired a new position in shares of Joby Aviation in the fourth quarter valued at about $33,000. 52.85% of the stock is currently owned by institutional investors and hedge funds.

Joby Aviation Trading Up 3.7% JOBY opened at $7.50 on Tuesday. Joby Aviation, Inc. has a twelve month low of $6.89 and a twelve month high of $20.95. The company has a quick ratio of 22.05, a current ratio of 22.06 and a debt-to-equity ratio of 0.36. The company has a fifty day moving average of $9.57 and a 200-day moving average of $10.29. The stock has a market cap of $7.37 billion, a PE ratio of -6.52 and a beta of 2.71.

Joby Aviation (NYSE:JOBY – Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.12) EPS for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.09. Joby Aviation had a negative net margin of 1,232.62% and a negative return on equity of 60.54%. The business had revenue of $24.25 million for the quarter, compared to analysts’ expectations of $20.17 million. During the same quarter in the prior year, the firm posted ($0.11) earnings per share. On average, sell-side analysts predict that Joby Aviation, Inc. will post -0.83 EPS for the current year.

Insider Transactions at Joby Aviation In related news, insider Kate Dehoff sold 14,240 shares of the business’s stock in a transaction on Tuesday, July 14th. The shares were sold at an average price of $7.73, for a total transaction of $110,075.20. Following the transaction, the insider owned 180,179 shares in the company, valued at $1,392,783.67. The trade was a 7.32% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Joeben Bevirt sold 421,019 shares of the firm’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $10.38, for a total transaction of $4,370,177.22. Following the completion of the sale, the chief executive officer owned 31,678,802 shares of the company’s stock, valued at $328,825,964.76. The trade was a 1.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 1,125,580 shares of company stock valued at $12,172,117. 20.35% of the stock is owned by insiders.

Wall Street Analyst Weigh In Several equities research analysts recently weighed in on JOBY shares. Needham & Company LLC reaffirmed a “buy” rating and set a $18.00 price objective on shares of Joby Aviation in a research report on Wednesday, May 6th. Morgan Stanley lowered their price objective on shares of Joby Aviation from $15.00 to $13.00 and set an “equal weight” rating for the company in a research report on Wednesday, May 6th. Wall Street Zen upgraded Joby Aviation from a “strong sell” rating to a “sell” rating in a research note on Sunday, May 10th. Canaccord Genuity Group decreased their price target on Joby Aviation from $15.50 to $11.50 and set a “hold” rating on the stock in a research note on Thursday, May 7th. Finally, Weiss Ratings raised Joby Aviation from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 14th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, Joby Aviation currently has an average rating of “Reduce” and an average target price of $13.64.

View Our Latest Analysis on JOBY

About Joby Aviation (Free Report)

Joby Aviation Inc is an aerospace company focused on developing electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. The company’s core mission is to provide zero-emission aerial ridesharing services, combining the speed of helicopters with the cost efficiency and environmental benefits of electric propulsion. Joby’s eVTOL design emphasizes low noise profiles and high reliability, positioning the company to address congestion challenges in major metropolitan areas.

The company’s flagship aircraft is designed to carry a pilot and up to four passengers, offering point-to-point travel at speeds competitive with ground transportation.

Featured Articles Five stocks we like better than Joby Aviation The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Joby Aviation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joby Aviation and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEFifth Third Bancorp (NASDAQ:FITB) Given New $65.00 Price Target at DA Davidson

NEXT HEADLINE »Amova Asset Management Americas Inc. Has $24.91 Million Stake in Futu Holdings Limited Sponsored ADR $FUTU

Here are three stocks with buy rank and strong value characteristics for investors to consider today, July 21:

ORIX Corporation (IX - Free Report) : This financial services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing by 55.7% over the last 60 days.

ORIX has a price-to-earnings ratio (P/E) of 8.28 compared with 9.70 for the industry. The company possesses a Value Scoreof A.

Arrow Electronics, Inc. (ARW - Free Report) : This technology solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing by 6.6% over the last 60 days.

Arrow Electronics has a price-to-earnings ratio (P/E) of 10.79 compared with 28.90 for the industry. The company possesses a Value Score of A.

Designer Brands Inc. (DBI - Free Report) : This footwear company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.6% over the last 60 days.

Designer Brands has a price-to-earnings ratio (P/E) of 15.05 compared with 22.73 for the S&P. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

HomeDividends AnalysisREITs AnalysisReal Estate Analysis

SummaryHost Hotels & Resorts is reaffirmed as a buy, supported by strong earnings momentum and portfolio upgrades.HST benefits from luxury segment tailwinds, robust operating margins, and a conservative, investment-grade balance sheet.Renovation-driven growth, resilient FFO trends, and secure dividend coverage underpin the investment thesis, though dividend growth lags peers.Valuation appears attractive on forward P/FFO, but upside is capped by return targets; technicals remain bullish with strong market support. Alexander Konoplev/iStock via Getty Images

The Hotel REIT Looking For 5 Earnings Beats in a Row While summer season in many parts of the world has been on a hot streak lately, another season we are in the middle of

1.88K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of RLJ, APLE, INN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Author actively invests in a diversified portfolio of REITs and REIT mutual funds, including names mentioned as peers in this article: INN, RLJ, APLE.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Umělá inteligence už dávno není jen příběhem o Nvidii, datových centrech a stále výkonnějších modelech. Podle AI specialisty Šimona Podhájského se investoři často příliš soustředí na samotné modely a přehlížejí oblasti, kde se bude vytvářet skutečná hodnota. V podcastu Patria Finance hovořil o budoucnosti AI agentů, investičních příležitostech i o tom, proč mohou být největším rizikem AI systémy, které začneme používat bez dostatečné kontroly.

Když se dnes mluví o umělé inteligenci, debata se často točí kolem několika známých jmen. OpenAI, Anthropic, Google, Nvidia nebo Meta představují tváře technologické revoluce, která během posledních let zásadně změnila očekávání investorů i firem. Podle Šimona Podhájského, AI inženýra ze společnosti Curebase a dlouholetého praktika v oblasti jazykových modelů, je však skutečnost mnohem složitější.

„Myslím si, že hodně lidí si myslí, že záleží jenom na tom, kdo má ty modely. A že to jsou Amerika a Čína. Já si naopak myslím, že hodně záleží na aplikační vrstvě a na těch ‚harnessech‘, tedy na tom, jak si ten model osedláme a použijeme,“ říká Podhájský. Právě způsob nasazení AI podle něj často rozhoduje více než samotná kvalita základního modelu.

AI už je dál, než si většina lidí myslí

Z pohledu technologického vývoje vidí Podhájský současný stav AI podobně jako internet na konci 90. let. „Řekl bych, že jsme někde kolem roku 1999. Už vidíme ten slib, ale současně investujeme do AI i v oblastech, které ještě nemusí být rentabilní,“ říká.

Zároveň odmítá představu, že budoucnost AI je teprve před námi. „Budoucnost už je do značné míry tady, jenom není rovnoměrně rozdělená,“ parafrázuje známý výrok Williama Gibsona. Podle něj už dnes existují firmy, které využívají AI agenty jako digitální kolegy schopné samostatně vykonávat celé pracovní procesy. Většina trhu se s těmito možnostmi teprve seznamuje.

Věří i v možnost vzniku takzvaného „one-person unicorn“, tedy miliardové firmy řízené jediným člověkem za pomoci AI. „Může se vyplnit předpověď Sama Altmana, že vznikne první jednorožec vytvořený a provozovaný jediným člověkem. Struktura firem se může výrazně změnit,“ říká Podhájský.

Velkou hodnotu vytvoří data

Přestože veřejnost často sleduje souboj největších modelů, Podhájský vidí konkurenční výhodu firem jinde. „Myslím si, že datasety a jejich kvalita jsou čím dál důležitější pro dosahování dalších úrovní modelů,“ vysvětluje. To platí nejen při samotném trénování AI, ale také při jejím nasazení ve firmách.

Podle něj dnes řada společností řeší AI dříve, než mají vyřešenou vlastní datovou infrastrukturu. „Firmy si často řeknou: všichni mají AI, musíme mít také AI. Ale přitom ještě nemají správně nastavené vlastní datové sklady nebo procesy,“ upozorňuje. Právě schopnost pracovat s unikátními daty vidí jako jeden z nejdůležitějších investičních příkopů budoucnosti. „Pokud bych hledal investiční „moat“, hledal bych firmu s vlastním datasetem, který konkurence nedokáže jednoduše replikovat,“ říká.

Software bude levnější. Ne všechny firmy to přežijí

Jedním z momentálně nejdiskutovanějších témat na trzích je dopad AI na softwarový sektor. Akcie některých tradičních softwarových firem v posledních kvartálech zaostávaly právě kvůli obavám investorů, že vývoj softwaru bude díky AI výrazně levnější. Podhájský tyto obavy do značné míry sdílí. „Myslím si, že tvorba softwaru bude čím dál levnější a že AI bude ukusovat stále větší část vývoje,“ říká.

Současně ale upozorňuje, že nejde jen o to, že si jednotlivci budou schopni vytvářet vlastní aplikace. „Větší problém je, že se zmenšuje konkurenční výhoda zavedených firem vůči novým konkurentům. Je jednodušší architektovat složité aplikace než dřív,“ vysvětluje.

Neznamená to však automatický zánik velkých softwarových společností. Jako příklad uvádí Adobe. Nevěří totiž, že by AI vedla k masovému vytváření plnohodnotných alternativ Photoshopu. „Trh podle mě Adobe podhodnocuje možná až příliš. AI sice ukusuje část jeho využití, ale neznamená to automaticky konec firmy,“ míní.

Kde leží investiční příležitosti

Přestože se Podhájský označuje za zastánce hypotézy efektivních trhů a většinu vlastních investic směřuje do ETF fondů, vidí několik oblastí, které mohou být zajímavé i pro investory. První z nich souvisí s rostoucí produkcí obsahu generovaného AI. „Soudy, grantové agentury nebo vydavatelé knih se začínají topit v množství textů generovaných umělou inteligencí,“ upozorňuje. Obrovský potenciál proto vidí v nástrojích schopných tento obsah filtrovat. „Čekám, že přijde software, který bude umět lépe rozlišit, co musí zkontrolovat člověk a co lze zpracovat automaticky,“ říká.

Ještě větší příležitost ale vidí ve vědeckém výzkumu. „Oblast, od které si slibuji výrazný posun, je automatizovaná věda,“ tvrdí. Zmiňuje přitom například český startup Theorema, který se zaměřuje na automatizaci laboratorního výzkumu. Tato oblast navazuje na úspěchy projektů typu AlphaFold, jenž dramaticky urychlil výzkum proteinových struktur. „AI bude nejúspěšnější tam, kde je jednoduché ověřit správné řešení,“ vysvětluje Podhájský.

Největší riziko? Ne Skynet, ale postupná ztráta kontroly

I když v představách lidí často převažuje hrozba AI typu Skynet, Podhájský za pravděpodobnější hrozbu považuje něco mnohem méně nápadného. „Myslím si, že AI nám ublíží tam, kde ji nasadíme a neumíme ověřit, jestli dělá správnou věc,“ říká. Jako příklad uvádí schvalování hypoték, přijímání zaměstnanců nebo vyhodnocování žádostí.

Zvláštní obavy má i z fenoménu, který označuje jako postupné vzdávání se rozhodovacích pravomocí. „Může se stát, že budeme čím dál víc delegovat ekonomicky relevantní činnosti na AI agenty a přestaneme sami rozhodovat,“ upozorňuje.

Podle něj dnes existují dva způsoby využití AI. Ten první označuje za pozitivní. „Lidé používají AI jako kognitivní multiplikátor. Zkoumají víc věcí, rychleji získávají informace a lépe přemýšlejí.“ Druhý scénář je ale problematičtější. „AI se může stát kognitivní protézou. Místo toho, abychom přemýšleli, delegujeme celé rozhodnutí na stroj,“ varuje.

AI jako nástroj, ne náhrada člověka

Přesto Podhájský zůstává v zásadě optimistou. AI používá denně a považuje ji za mimořádně užitečný nástroj. Existují však oblasti, které by stroji nesvěřil. „Nepoužil bych AI na svatební sliby,“ říká s úsměvem.

Stejně skeptický je k tomu, aby AI plánovala zásadní životní rozhodnutí. „Nepoužiju ji na tvorbu plánů toho, co chci se svým životem dělat. Ty plány, se kterými většinou přijde, jsou příliš průměrné.“

Právě zde podle něj leží hranice mezi nástrojem, který člověka posiluje, a technologií, která ho postupně zbavuje autonomie.A to může být nakonec mnohem důležitější otázka než to, který model právě vede benchmarky nebo zda Nvidia dokáže i za několik let obhájit své výjimečné marže.

Posted by Defense World Staff on Jul 21st, 2026

Allspring Global Investments Holdings LLC raised its position in SkyWest, Inc. (NASDAQ:SKYW – Free Report) by 21.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 215,017 shares of the transportation company’s stock after acquiring an additional 38,135 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.54% of SkyWest worth $20,147,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in SkyWest by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,590 shares of the transportation company’s stock worth $2,061,000 after buying an additional 1,034 shares during the period. United Services Automobile Association purchased a new position in SkyWest in the 1st quarter valued at approximately $227,000. M&T Bank Corp grew its stake in shares of SkyWest by 7.6% in the second quarter. M&T Bank Corp now owns 2,825 shares of the transportation company’s stock worth $290,000 after acquiring an additional 199 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of SkyWest by 118.5% in the second quarter. EverSource Wealth Advisors LLC now owns 625 shares of the transportation company’s stock worth $64,000 after acquiring an additional 339 shares in the last quarter. Finally, First Trust Advisors LP increased its position in shares of SkyWest by 8.8% during the second quarter. First Trust Advisors LP now owns 85,577 shares of the transportation company’s stock worth $8,812,000 after acquiring an additional 6,938 shares during the period. 81.30% of the stock is currently owned by hedge funds and other institutional investors.

SkyWest Trading Up 2.2% Shares of SkyWest stock opened at $99.34 on Tuesday. The company has a current ratio of 0.62, a quick ratio of 0.51 and a debt-to-equity ratio of 0.66. The company has a fifty day simple moving average of $90.91 and a 200-day simple moving average of $94.49. The stock has a market cap of $3.94 billion, a price-to-earnings ratio of 9.52, a PEG ratio of 1.41 and a beta of 1.45. SkyWest, Inc. has a 12-month low of $77.89 and a 12-month high of $123.94.

SkyWest (NASDAQ:SKYW – Get Free Report) last released its quarterly earnings data on Thursday, April 23rd. The transportation company reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.15 by $0.35. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $993.06 million. SkyWest had a net margin of 10.42% and a return on equity of 15.55%. SkyWest’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.42 earnings per share. On average, equities analysts forecast that SkyWest, Inc. will post 10.58 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth Several analysts have recently issued reports on SKYW shares. TD Cowen increased their price objective on SkyWest from $98.00 to $115.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Citigroup boosted their target price on SkyWest from $95.00 to $105.00 and gave the stock a “neutral” rating in a research note on Friday, June 26th. Weiss Ratings upgraded SkyWest from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday. Finally, The Goldman Sachs Group lowered SkyWest from a “buy” rating to a “neutral” rating and reduced their price target for the company from $126.00 to $115.00 in a research report on Thursday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $121.17.

Get Our Latest Analysis on SKYW

SkyWest Profile (Free Report)

SkyWest, Inc (NASDAQ: SKYW) is a regional airline holding company that provides air transportation services through its primary subsidiary, SkyWest Airlines. The company operates flights under capacity purchase agreements with major carriers such as United Airlines, Delta Air Lines, American Airlines and Alaska Airlines. By specializing in regional connectivity, SkyWest links smaller communities to larger hubs using a fleet of regional jets and turboprop aircraft.

Headquartered in St. George, Utah, SkyWest oversees all aspects of its airline operations, including flight scheduling, crew training and aircraft maintenance.

Featured Articles Five stocks we like better than SkyWest The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for SkyWest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkyWest and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAlpha Zero LLC Has $10.95 Million Stock Holdings in JPMorgan U.S. Quality Factor ETF $JQUA

NEXT HEADLINE »Alpha Zero LLC Takes $1.24 Million Position in iShares Ultra Short-Term Bond Active ETF $ICSH

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. cut its holdings in shares of 10x Genomics (NASDAQ:TXG – Free Report) by 7.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,104,178 shares of the company’s stock after selling 381,975 shares during the period. 10x Genomics comprises about 1.5% of Amova Asset Management Americas Inc.’s portfolio, making the stock its 18th biggest position. Amova Asset Management Americas Inc. owned about 4.00% of 10x Genomics worth $108,311,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Geneos Wealth Management Inc. acquired a new position in shares of 10x Genomics in the fourth quarter valued at approximately $38,000. Larson Financial Group LLC boosted its position in 10x Genomics by 164.4% in the 4th quarter. Larson Financial Group LLC now owns 2,364 shares of the company’s stock valued at $39,000 after buying an additional 1,470 shares during the period. Fifth Third Bancorp acquired a new position in shares of 10x Genomics in the first quarter worth $50,000. Van ECK Associates Corp grew its stake in shares of 10x Genomics by 85.9% in the fourth quarter. Van ECK Associates Corp now owns 3,668 shares of the company’s stock worth $60,000 after acquiring an additional 1,695 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of 10x Genomics by 203.9% during the second quarter. EverSource Wealth Advisors LLC now owns 7,490 shares of the company’s stock worth $87,000 after acquiring an additional 5,025 shares during the period. Institutional investors and hedge funds own 84.68% of the company’s stock.

Wall Street Analysts Forecast Growth TXG has been the subject of a number of recent research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of 10x Genomics in a report on Wednesday, June 24th. Canaccord Genuity Group increased their price target on 10x Genomics from $32.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Bank of America boosted their price objective on 10x Genomics from $21.00 to $30.00 and gave the stock a “neutral” rating in a research report on Monday, April 20th. Leerink Partners upped their target price on shares of 10x Genomics from $23.00 to $40.00 and gave the stock a “market perform” rating in a research note on Friday. Finally, Morgan Stanley raised their target price on shares of 10x Genomics from $22.00 to $37.00 and gave the company an “equal weight” rating in a report on Thursday, July 9th. Four equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, 10x Genomics has a consensus rating of “Hold” and an average price target of $32.08.

Check Out Our Latest Stock Analysis on 10x Genomics

Insider Activity at 10x Genomics In other 10x Genomics news, CEO Serge Saxonov sold 30,000 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $34.44, for a total value of $1,033,200.00. Following the completion of the transaction, the chief executive officer owned 1,108,380 shares in the company, valued at $38,172,607.20. This represents a 2.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Shehnaaz Suliman sold 5,723 shares of the firm’s stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $32.63, for a total value of $186,741.49. Following the transaction, the director directly owned 31,722 shares in the company, valued at approximately $1,035,088.86. The trade was a 15.28% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 91,309 shares of company stock valued at $2,581,357 in the last ninety days. 8.84% of the stock is currently owned by insiders.

10x Genomics Stock Down 1.2% Shares of 10x Genomics stock opened at $43.22 on Tuesday. 10x Genomics has a 52 week low of $11.16 and a 52 week high of $46.32. The firm’s 50 day moving average is $32.61 and its two-hundred day moving average is $24.90. The firm has a market capitalization of $5.49 billion, a P/E ratio of -254.24 and a beta of 2.05.

10x Genomics (NASDAQ:TXG – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.19. The business had revenue of $150.84 million during the quarter, compared to the consensus estimate of $146.41 million. 10x Genomics had a negative net margin of 3.55% and a negative return on equity of 2.86%. The company’s revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.28) EPS. As a group, research analysts expect that 10x Genomics will post -0.79 earnings per share for the current fiscal year.

10x Genomics Company Profile (Free Report)

10x Genomics, Inc is a biotechnology company specializing in advanced genomic analysis solutions that enable researchers to explore biology at unprecedented resolution. The company develops and manufactures integrated hardware, consumables and software products for single-cell sequencing and spatial genomics. Its flagship Chromium product line supports applications in single-cell RNA sequencing, immune profiling and genome assembly, while the Visium and Xenium platforms offer spatial transcriptomics and in situ analysis, respectively.

Founded in 2012 and headquartered in Pleasanton, California, 10x Genomics serves a global customer base that includes academic institutions, pharmaceutical and biotechnology companies, and government research organizations.

Recommended Stories Five stocks we like better than 10x Genomics The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for 10x Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 10x Genomics and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECRISPR Therapeutics AG $CRSP Shares Sold by Amova Asset Management Americas Inc.

NEXT HEADLINE »Tempus AI, Inc. $TEM Stake Boosted by Amova Asset Management Americas Inc.

Posted by Defense World Staff on Jul 21st, 2026

Andra AP fonden grew its stake in Reddit Inc. (NYSE:RDDT – Free Report) by 152.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 172,100 shares of the company’s stock after buying an additional 103,972 shares during the period. Andra AP fonden owned approximately 0.09% of Reddit worth $23,173,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Ascentis Independent Advisors bought a new position in Reddit in the first quarter valued at $30,000. LOM Asset Management Ltd bought a new stake in Reddit during the fourth quarter worth about $33,000. Geneos Wealth Management Inc. boosted its holdings in shares of Reddit by 344.6% in the 1st quarter. Geneos Wealth Management Inc. now owns 369 shares of the company’s stock worth $39,000 after purchasing an additional 286 shares in the last quarter. V Square Quantitative Management LLC purchased a new position in shares of Reddit in the 1st quarter worth about $43,000. Finally, Cassaday & Co Wealth Management LLC bought a new position in Reddit during the first quarter valued at approximately $46,000.

Insider Activity In other Reddit news, CAO Michelle Marie Reynolds sold 808 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $200.00, for a total transaction of $161,600.00. Following the completion of the transaction, the chief accounting officer owned 15,060 shares of the company’s stock, valued at approximately $3,012,000. This trade represents a 5.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Steve Ladd Huffman sold 18,000 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $178.26, for a total transaction of $3,208,680.00. Following the sale, the chief executive officer owned 373,814 shares in the company, valued at approximately $66,636,083.64. This trade represents a 4.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 169,141 shares of company stock worth $28,680,845 in the last quarter. 28.48% of the stock is owned by company insiders.

Reddit Stock Up 0.5% Shares of RDDT stock opened at $182.08 on Tuesday. The firm has a market capitalization of $35.05 billion, a price-to-earnings ratio of 52.02 and a beta of 1.93. The stock has a fifty day moving average of $173.23 and a 200 day moving average of $168.93. Reddit Inc. has a 52 week low of $119.27 and a 52 week high of $282.95.

Reddit (NYSE:RDDT – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.62 by $0.39. Reddit had a net margin of 28.60% and a return on equity of 25.48%. The business had revenue of $663.41 million for the quarter, compared to the consensus estimate of $607.74 million. During the same period in the previous year, the firm earned $0.13 EPS. The company’s quarterly revenue was up 69.1% compared to the same quarter last year. Equities research analysts anticipate that Reddit Inc. will post 4.85 earnings per share for the current year.

Wall Street Analysts Forecast Growth Several research firms recently issued reports on RDDT. Truist Financial set a $265.00 price target on Reddit in a research report on Friday, May 1st. Oppenheimer reissued an “outperform” rating and set a $225.00 price objective on shares of Reddit in a research note on Friday, May 1st. Wells Fargo & Company raised their target price on shares of Reddit from $176.00 to $187.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 7th. Citigroup reaffirmed a “market outperform” rating on shares of Reddit in a research note on Tuesday, May 26th. Finally, The Goldman Sachs Group reiterated a “neutral” rating and set a $200.00 price target on shares of Reddit in a report on Friday, May 1st. Nineteen investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat, Reddit presently has a consensus rating of “Moderate Buy” and an average price target of $232.48.

Read Our Latest Report on Reddit

Reddit Company Profile (Free Report)

Reddit is an online social news aggregation, discussion and content-sharing platform organized around user-created communities called “subreddits,” each focused on a particular topic or interest. Registered users submit links, text posts, images and video, and community members vote and comment to surface popular content. The site is accessed via its web platform and mobile apps for iOS and Android, and it supports live events such as Ask Me Anything (AMA) sessions and community-driven discussions.

Founded in 2005 by Steve Huffman and Alexis Ohanian, Reddit is headquartered in San Francisco and serves a global audience with particularly large user bases in the United States and other English-speaking markets.

Featured Stories Five stocks we like better than Reddit The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story Want to see what other hedge funds are holding RDDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Reddit Inc. (NYSE:RDDT – Free Report).

Receive News & Ratings for Reddit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reddit and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAndra AP fonden Increases Stock Position in Amphenol Corporation $APH

NEXT HEADLINE »Andra AP fonden Has $24.08 Million Position in Kinross Gold Corporation $KGC

Posted by Defense World Staff on Jul 21st, 2026

Amova Asset Management Americas Inc. raised its stake in Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 23.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 4,326,313 shares of the company’s stock after purchasing an additional 821,490 shares during the quarter. Tempus AI accounts for 2.8% of Amova Asset Management Americas Inc.’s portfolio, making the stock its 8th biggest position. Amova Asset Management Americas Inc. owned 2.42% of Tempus AI worth $195,549,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in the stock. JPL Wealth Management LLC bought a new stake in Tempus AI during the 3rd quarter valued at $26,000. Los Angeles Capital Management LLC bought a new stake in Tempus AI in the 4th quarter worth $27,000. Harvest Fund Management Co. Ltd bought a new stake in Tempus AI in the 3rd quarter worth $38,000. Danske Bank A S purchased a new position in shares of Tempus AI in the third quarter valued at about $48,000. Finally, Sunbelt Securities Inc. purchased a new position in shares of Tempus AI in the third quarter valued at about $52,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analysts Set New Price Targets A number of analysts have recently weighed in on TEM shares. Wall Street Zen lowered shares of Tempus AI from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. TD Cowen restated a “buy” rating on shares of Tempus AI in a report on Wednesday, July 15th. HC Wainwright lowered their price target on Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a research report on Monday, May 11th. Lake Street Capital cut Tempus AI to a “hold” rating in a report on Monday. Finally, Guggenheim lifted their price objective on Tempus AI from $60.00 to $65.00 and gave the stock a “buy” rating in a research report on Thursday. Nine investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $68.92.

Get Our Latest Stock Report on TEM

Insider Activity In other news, Director Jennifer A. Doudna sold 2,673 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $55.00, for a total transaction of $147,015.00. Following the sale, the director owned 25,942 shares in the company, valued at approximately $1,426,810. The trade was a 9.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Ryan Fukushima sold 33,284 shares of the company’s stock in a transaction dated Wednesday, July 8th. The stock was sold at an average price of $57.39, for a total transaction of $1,910,168.76. Following the completion of the sale, the chief executive officer directly owned 167,763 shares in the company, valued at $9,627,918.57. This represents a 16.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 616,043 shares of company stock worth $31,748,593. 24.26% of the stock is currently owned by corporate insiders.

Tempus AI Stock Down 7.7% Shares of NASDAQ:TEM opened at $48.41 on Tuesday. The firm has a market capitalization of $8.69 billion, a P/E ratio of -28.15 and a beta of 3.46. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. The stock has a 50 day moving average price of $51.60 and a 200-day moving average price of $53.91. Tempus AI, Inc. has a 52-week low of $41.73 and a 52-week high of $104.32.

Tempus AI (NASDAQ:TEM – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.08. The company had revenue of $348.12 million for the quarter, compared to analyst estimates of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm’s revenue was up 36.1% on a year-over-year basis. During the same period in the previous year, the company posted ($0.24) earnings per share. As a group, equities research analysts anticipate that Tempus AI, Inc. will post -1.35 EPS for the current fiscal year.

Tempus AI Profile (Free Report)

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.

See Also Five stocks we like better than Tempus AI The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence Is Domino’s Stock Serving Up a Buying Opportunity? A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free Why Gold Miners Could Be the Market’s Biggest Comeback Story

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE10x Genomics $TXG Shares Sold by Amova Asset Management Americas Inc.

NEXT HEADLINE »AlTi Global Inc. Invests $701,000 in Vanguard Small-Cap Value ETF $VBR